Document:

EX-4.1

 Exhibit 4.1 

EXECUTION COPY 
 WARRANT
AGREEMENT 
 THIS WARRANT AGREEMENT (this “Agreement”), dated as of July 30, 2014, is by and between
EveryWare Global, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”). 

WHEREAS, the Company has entered into that certain Waiver and Amendment Number One to the Term Loan Agreement, dated as of
July 30, 2014, among the Company, Anchor Hocking, LLC, a Delaware limited liability company, Oneida Ltd., a Delaware corporation Universal Tabletop, Inc., a Delaware corporation, the Lenders party to the listed on the signature pages thereto
and constituting the Required Lenders (as defined therein), each other subsidiary of Holdings party thereto and Deutsche Bank AG New York Branch, as Administrative Agent (the “Term Loan Agreement”), pursuant to which the
Lenders (as defined therein) will be issued an aggregate of 2,958,670 warrants of the Company (the “Warrants”); 

WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in
connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; 
 WHEREAS, the Company
desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the
Warrants; and 
 WHEREAS, all acts have been performed which are necessary to make the Warrants, when executed on behalf of the
Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement. 

NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows: 

1. Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent
hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement. 
 2.
Warrants. 
 2.1 Form of Warrant. Each Warrant shall be issued in registered form only and shall be in substantially the form
of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board of Directors of the Company (the “Board”), President, Chief
Executive Officer, Chief Financial Officer, Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person
signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. 

  
 1 

 2.2 Effect of Countersignature. Unless and until countersigned by the Warrant Agent
pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof. 
 2.3
Register. 
 2.3.1 Warrant Register. The Warrant Agent shall maintain a register for the Warrants in which the
Warrant Agent shall record the name and address of each person or entity in whose name Warrants have been issued (including the name and address of each transferee) and the number of Warrants held by such person or entity (the “Warrant
Register”), for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective
holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. The Warrant Agent shall keep the register open and available at all times during business hours for inspection by any
holder of Warrants hereunder or its legal representatives. 
 2.3.2 Registered Holder. Prior to due presentment for
registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder” or
“Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on the Warrant Certificate (as defined below) made by anyone other than the
Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. 

2.4 Restrictive Legend. Any Warrant issued pursuant to this Agreement, including upon transfer or replacement of any Warrant shall be
imprinted with the following legend, in addition to any legend required under applicable state securities laws: 
 THIS SECURITY, AS WELL AS
THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS SECURITY, AS WELL AS THE COMMON STOCK OF THE
COMPANY UNDERLYING THIS SECURITY, MAY NOT BE OFFERED FOR SALE, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED (I) IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, (II) IN THE ABSENCE OF AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS, AS EVIDENCED (IF REQUIRED BY THE COMPANY) BY A LEGAL OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT, OR (III) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER REPRESENTATION

  
 2 

 
LETTER AND A BROKER REPRESENTATION LETTER, IN EITHER CASE AS MAY BE APPLICABLE) THAT THE SECURITIES MAY BE SOLD PURSUANT TO SUCH RULE). NO REPRESENTATION IS MADE BY THE COMPANY AS TO THE
AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT FOR RESALES OF THIS SECURITY, OR THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY. 

2.5 Shelf Registrations. 

2.5.1 As promptly as practicable after the date hereof, the Company shall prepare and file with the United States Securities
and Exchange Commission (the “SEC”), one or more Registration Statements (collectively, the “Shelf Registration Statement”) for an offering to be made on a delayed or continuous basis pursuant to Rule
415 of the Securities Act of 1933, and the rules and regulations of the SEC promulgated thereunder, as from time to time amended (the “Securities Act”) registering the resale from time to time of Common Stock (as defined
below) issued or issuable under the Warrants by Holders (“Electing Holders”) of Warrants and/or shares of Common Stock so issued or issuable (such Common Stock, collectively, “Registrable Securities”)
who have provided the Company with a Notice and Questionnaire in the Form of Exhibit B (the “Notice and Questionnaire”). The Company shall give written notice of the filing of each Shelf Registration Statement (and
each amendment thereto) at least fifteen (15) days prior to filing each such Registration Statement to all Holders of Registrable Securities, together with a copy of such Notice and Questionnaire and a request to complete and return such Notice
and Questionnaire, and shall include in such Registration Statements all Registrable Securities of Electing Holders. The Shelf Registration Statement shall be on Form S-3 if the Company is eligible to use Form S-3 or another appropriate form
permitting registration of such Common Stock for resale. The Company shall use reasonable best efforts to cause the Shelf Registration Statement to be declared effective under the Securities Act as soon as possible after filing, and once effective,
to keep the Shelf Registration Statement continuously effective under the Securities Act at all times until the earlier of (x) three months following the Expiration Date and (y) the date on which (i) all shares of Common Stock issued
or issuable under the Warrants by persons who are not affiliates of the Company are or would upon issuance be freely tradable under United States federal securities laws subject only to the requirement in Rule 144(i)(2) that the Company have filed
all required SEC reports (other than Form 8-K reports) in the preceding 12 months and (ii) the share certificates for such Common Stock that would be issued following transfer pursuant to Rule 144(i)(2) would be issued without any restrictive
legends (the “Effectiveness Period”). 
 2.5.2 The Company shall at its expense: 

(a) prepare and file with the SEC such amendments and post-effective amendments to each Shelf Registration Statement as may be
necessary to keep such Shelf Registration Statement continuously effective for the Effectiveness Period; cause the related Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to Rule 424
(or any similar provisions then in force) under the Securities Act; and use reasonable efforts to comply with the provisions of the Securities Act applicable to it; 

(b) use its reasonable best efforts to (i) register or qualify the Common Stock covered by the Shelf Registration
Statement under such securities or “blue sky” laws of any applicable jurisdiction in the United States and (ii) take such action necessary to cause 

  
 3 

 
such Common Stock covered by the Shelf Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations
of the Company and do any and all other acts and things that may be necessary or advisable to enable the Registered Holders to consummate the disposition of such Common Stock in such jurisdictions; provided, however, that the Company
shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction
where it is not then otherwise so subject; 
 (c) cause all such Common Stock registered pursuant hereto to be listed on the
principal Exchange (as defined below) on which similar securities issued by the Company are then listed; 
 (d) maintain a
transfer agent and registrar for the Company’s Common Stock; 
 (e) as promptly as reasonably practicable, but within
three (3) business days in any event, give notice to the Registered Holders (1) when any Prospectus, Prospectus supplement, Registration Statement or post-effective amendment to a Shelf Registration Statement has been filed with the SEC
and, with respect to a Shelf Registration Statement or any post-effective amendment, when the same has been declared effective and (2) of any request, following the effectiveness of a Shelf Registration Statement under the Securities Act, by
the SEC or any other federal or state governmental authority for amendments or supplements to such Shelf Registration Statement or related Prospectus or for additional information; 

(f) notify the Registered Holders in writing of the effectiveness of the Shelf Registration Statement and furnish to the
Registered Holders, without charge, such number of copies of the Shelf Registration Statement (including any amendments, supplements and exhibits), the Prospectus contained therein (including each preliminary prospectus and all related amendments
and supplements) and such other documents as the Registered Holders may reasonably request in order to facilitate the sale of the Common Stock in the manner described in the Shelf Registration Statement; 

(g) promptly prepare and file with the SEC from time to time such amendments and supplements to the Shelf Registration
Statement and Prospectus used in connection therewith (or file a new Shelf Registration Statement) as may be necessary to keep the Shelf Registration Statement effective, to ensure the information pertaining to the Electing Holders is current, and
to comply with the provisions of the Securities Act with respect to the disposition of all such Common Stock during the Effectiveness Period; 

(h) give notice to the Registered Holders as promptly as practicalbe (and in any event within three business days) following
notice to the Company (1) of the issuance by the SEC or any other federal or state governmental authority of any stop order or injunction suspending or enjoining the use of any Prospectus or the effectiveness of a Shelf Registration Statement
or the initiation or threatening of any proceedings for that purpose, (2) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Common Stock for sale
in any jurisdiction or the initiation or threatening of any proceeding for such purpose, and (3) of the happening of any event that makes any statement made in a Shelf Registration Statement or the related Prospectus untrue in any material
respect or that requires changes in order to make the statements therein not misleading; 

  
 4 

 (i) cooperate with each Registered Holder and their respective counsel in
connection with any filings required to be made with the Financial Industry Regulatory Authority, Inc., and use its reasonable best efforts to make or cause to be made any filings required to be made by an issuer with the Financial Industry
Regulatory Authority, Inc. in connection with the filing of the Shelf Registration Statement; 
 (j) pay the filing fee
covering all such Common Stock at the time an Shelf Registration Statement is filed; 
 (k) during the Effectiveness Period,
if at any time the Company is required to re-evaluate its eligbility to utilize a form of registration statement and the Company determines that it is not eligible to use such form, use its reasonable best efforts to refile the Shelf Registration
Statement on such form as it is eligible to use and keep such registration statement effective during the Effectiveness Period; and 

(l) otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the
Holders, in connection with such registration. 
 2.5.3 Notwithstanding the above requirements, the Company shall not be required to amend
or supplement any registration statement, any related prospectus or any document incorporated therein by reference for a period (the “Black Out Period”) not to exceed, for so long as this Agreement is in effect, an aggregate
of 90 days in any calendar year, in the event that (A) an event occurs and is continuing as a result of which the registration statement, any related prospectus or any document incorporated therein by reference as then amended or supplemented
would, in the Company’s good faith judgment, contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading, and (B)(1) the Company determines in its good faith judgment that the disclosure of such event at such time would have a material adverse effect on the business, operations or prospects of the Company or (2) the disclosure otherwise
relates to a material business transaction which has not yet been publicly disclosed. 
 2.5.4 Each of the Electing Holders agrees that,
upon receipt of any notice from the Company of the happening of any event of the kind described in Section 2.5.2(h), such Electing Holder will forthwith discontinue the disposition of Common Stock pursuant to the registration statement
until such Electing Holder receives copies of the supplemented or amended prospectus contemplated by such Section, and, if so directed by the Company, each Electing Holder will deliver to the Company (at the Company’s expense) all copies, other
than permanent file copies then in such Electing Holder’s possession, of the prospectus covering such Common Stock current at the time of receipt of such notice. Each Electing Holder also agrees to notify the Company of any event relating to
such Electing Holder that occurs that would require the preparation of a supplement or amendment to the prospectus so that such prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading. In accordance with the Notice and Questionnaire, the Company may require any holder of a Warrant or Common Stock issued upon exercise of a Warrant to furnish to the Company such
information regarding such holder and the intended distribution of the shares of Common Stock issuable upon exercise of the Warrant and such other information as the Company may from time to time reasonably request in writing in connection with the
registration. 

  
 5 

 3. Terms and Exercise of Warrants. 

3.1 Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder thereof, subject to the
provisions of such Warrant and of this Agreement, to purchase from the Company the number of shares of common stock of the Company (“Common Stock”) stated therein or any portion thereof, at an exercise price of $0.01 per
share (the “Warrant Price”), subject to the adjustments provided in Section 4 hereof. The term “Warrant Price” as used in this Warrant Agreement shall mean the price per share at which Common Stock may
be purchased at the time a Warrant is exercised. 
 3.2 Duration of Warrants. A Warrant may be exercised only during the period (the
“Exercise Period”) commencing on the date hereof and terminating at 5:00 p.m., New York City time on July 30, 2021 (the “Expiration Date”). Each Warrant not exercised on or before the Expiration
Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants
by delaying the Expiration Date; provided, that the Company shall provide at least twenty (20) days’ prior written notice of any such extension to Registered Holders of the Warrants; provided, further, that any such
extension shall be identical in duration among all the Warrants and the warrants issued by the Company (the “SPA Warrants”) pursuant to the Securities Purchase Agreement dated as of the date hereof among the Company and the
Investors (as defined therein). 
 3.3 Exercise of Warrants. 

3.3.1 Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant
Agent, may be exercised by the Registered Holder thereof by surrendering it at the office of the Warrant Agent, or at the office of its successor as Warrant Agent, in the Borough of Manhattan, City and State of New York, with the subscription form,
as set forth in the Warrant, duly executed, and by paying in full the Warrant Price for each full share of Common Stock as to which the Warrant is exercised, as follows: 

(a) with respect to the exercise of any Warrant on a “cash basis”, by wire transfer of immediately available funds, in good certified
check or good bank draft payable to the order of the Company; provided that the Registered Holder provides the information on the notice to purchase in the form attached to such Warrant (each, an “Exercise Notice”)
that is reasonably necessary for the Company to issue the Common Stock as to which such Warrant is exercised in compliance with U.S. federal securities law; or 

(b) with respect to the exercise of any Warrant on a “cashless basis”, by surrendering such Warrant for that number of shares of
Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying such Warrant or any portion thereof being exercised (at the election of the Registered Holder), multiplied by the
difference between the Fair Market Value, and the Warrant Price by (y) the Fair Market Value. “Fair Market Value” means (i) at any time the Common Stock is listed or quoted for trading on the New York Stock
Exchange, the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market, OTC Bulletin Board or any other national securities exchange (each, an “Exchange”),
the average last sale price of a share of Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which notice of exercise of such Warrant is sent to the Warrant Agent; or (ii) at any time the Common
Stock is not listed or quoted for trading on an Exchange, the fair market value of a share of Common Stock as shall be determined by the Board of Directors in its good faith judgment; 

  
 6 

 provided, however, that, notwithstanding the foregoing, the issuance of shares of Common Stock or
other securities upon the exercise of any Warrant shall be made without charge to the Registered Holder for any issue or other tax in respect thereof; provided, further, that if at any time the Common Stock is not a “covered
security” under Section 18(b) of the Securities Act, the Company may, at its option, require any exercise of Warrants to be made on a “cashless basis.” 

3.3.2 Issuance of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance
of the funds in payment of the Warrant Price (if payment is on a “cash basis” pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a certificate or certificates for the number of full
shares of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant for the number of shares as to
which such Warrant shall not have been exercised. The Company’s obligations to issue and deliver shares of Common Stock upon the exercise of any Warrants in accordance with the terms hereof are absolute and unconditional. Nothing herein shall
limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely
deliver certificates representing shares of Common Stock upon exercise of any Warrant as required pursuant to the terms hereof. 

3.3.3 Valid Issuance. All Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement
shall be validly issued, fully paid and nonassessable, and free and clear of all Liens. For purposes hereof, “Lien” means any mortgage, lien (statutory or otherwise), charge, pledge, hypothecation, conditional
sales agreement, adverse claim, title retention agreement or other security interest, encumbrance or other title defect in or on any interest or title of any vendor, lessor, lender or other secured party to or of such person or entity under any
conditional sale, trust receipt or other title retention agreement with respect to any property or asset of such person or entity. At any time that the Warrants are outstanding, the Company shall cause to be maintained all authorizations required
for the issuance of a number of shares of Common Stock which the Company may be liable to issue upon exercise of the Warrants from time to time remaining outstanding, in accordance with the terms and conditions this Agreement and the Warrants. All
shares of Common Stock delivered upon exercise of the Warrants shall be newly issued shares or shares held in treasury by the Company, shall have been duly authorized and validly issued and shall be fully paid and non-assessable and free of any Lien
and shall not be subject to any preemptive rights or similar rights and shall rank pari passu in all respects with other existing Common Stock. 

3.3.4 Date of Issuance. Each person or entity in whose name any certificate for Common Stock is issued shall for all
purposes be deemed to have become the holder of record of such Common Stock on the date on which the Warrant was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate, except that, if the
date of such surrender and payment is a date when the share transfer books of the Company are closed, such person or entity shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the
share transfer books are open. The Warrant Agent shall, upon request of the Holder, use its reasonable best efforts to record the ownership of the Warrant Shares upon exercise in book entry form rather than through the issuance of physical stock
certificates (provided that such book entry interests will continue to bear any required restrictive legends). 

  
 7 

 3.3.5 Closing of Books. The Company will at no time close its transfer
books against the transfer of any Warrant in any manner which interferes with the timely exercise hereof. 
 3.3.6 Listing
of Common Stock. In the time and manner required by any Exchange on which the Common Stock is listed or quoted for trading on the date in question (the “Trading Market”), the Company shall prepare and file with such
Trading Market additional shares listing application covering all the Common Stock issuable upon exercise of the Warrants and shall use its reasonable best efforts to take all steps necessary to cause all of the Common Stock issuable upon exercise
of the Warrants to be approved for listing on the Trading Market at all times. 
 4. Adjustments. The number of shares of Common Stock issuable upon
exercise of any Warrant, as well as the Warrant Price, is subject to adjustment from time to time as set forth in this Section 4. 

4.1 Share Dividends. 

4.1.1 Split-Ups. If after the date hereof, the number of outstanding shares of Common Stock is increased by a stock
dividend payable in Common Stock, or by a split-up or sub-division of Common Stock or other similar event, then, on the effective date of such stock dividend, split-up, sub-division or similar event, the number of shares of Common Stock issuable on
exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock, subject to the provisions of Section 4.7 below. 

4.1.2 Other Distributions. If after the date hereof the Company makes a distribution (a
“Distribution”) to the holders of its Common Stock (other than in connection with the liquidation, dissolution or winding up of the Company) of any asset (including cash or evidence of its indebtedness) or security (including
any subscription right) (the total value of the assets or securities so distributed, the “Distribution Amount”) other than a distribution referred to in Section 4.1.1, then the Company shall distribute to the
holder of each Warrant the portion of the Distribution Amount which a holder of the number of shares of Common Stock for which such Warrant is exercisable immediately prior to the Distribution would have owned or received immediately after and as a
result of such Distribution. 
 4.2 Aggregation of Shares. If after the date hereof, the number of outstanding shares of Common Stock
is decreased by a consolidation, combination, reverse stock split or reclassification of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the
number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding Common Stock, subject to the provisions of Section 4.7 hereof. 

4.3 Adjustments in Exercise Price. Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is
adjusted, as provided in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator
of which shall be the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately
thereafter. 

  
 8 

 4.4 Replacement of Securities upon Reorganization, etc. In case of any recapitalization,
reclassification or reorganization of the outstanding Common Stock (other than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of such Common Stock), or in the case of
any amalgamation, conversion, merger or consolidation of the Company with or into another corporation or other entity (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any
recapitalization, reclassification or reorganization of the outstanding Common Stock), or in the case of any sale, lease, license, transfer or conveyance to another corporation or entity of the assets or other property of the Company as an entirety
or substantially as an entirety in connection with which the Company is dissolved, liquidated or wound up, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions
specified in the Warrants and in lieu of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property
(including cash) receivable upon such recapitalization, reclassification, reorganization, amalgamation, conversion, merger or consolidation, or upon a dissolution, liquidation or winding up following any such sale, lease, license, transfer or
conveyance, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”); provided, however, that
(i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such amalgamation, conversion, merger or consolidation, or upon a dissolution,
liquidation or winding up following any such sale, lease, license, transfer or conveyance, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be
deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such amalgamation, conversion, merger or consolidation, or upon a dissolution, liquidation or winding up following any such sale,
lease, license, transfer or conveyance, that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock under circumstances in which, upon
completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of which
such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within
the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the outstanding Common Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such
holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had been
purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4. If any
recapitalization, reclassification or reorganization also results in a change in Common Stock covered by both subsection 4.1.1 or Section 4.2 and this Section 4.4, then such adjustment shall be made pursuant to both
subsection 4.1.1 or Section 4.2 and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive recapitalizations, reclassifications, reorganizations, amalgamations,
conversions, mergers or consolidations, sales, leases, licenses, transfers, conveyances and other similar transactions, and the Company shall not effect any such transaction unless, prior to the consummation thereof, the successor person or entity
(if other than the Company) resulting from such transaction, shall assume, by written instrument substantially similar in form and substance 

  
 9 

 
to this Agreement and reasonably satisfactory to the majority in interest of the Registered Holders, the obligation to deliver to the Registered Holder such shares of stock, securities or assets
which, in accordance with the foregoing provisions, such Registered Holder shall be entitled to receive upon exercise of the Warrants held by them. 

Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction contemplated by the
provisions of this Section 4.4, each Registered Holder shall have the right to elect prior to the consummation of such event or transaction, to give effect to the exercise rights contained herein instead of giving effect to the
provisions contained in this Section 4.4 with respect to Warrants held by such Registered Holder. 
 4.5 [INTENTIONALLY
OMITTED.] 
 4.6 Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon
exercise of a Warrant, the Company shall give prompt written notice thereof to the Warrant Agent, which notice shall state the increase or decrease, if any, in Warrant Price resulting from such adjustment and the increase or decrease, if any, in the
number of shares purchasable at the Warrant Price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in
Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date
or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event. 

In the event: (a) that the Company shall take a record of the holders of its Common Stock (or other capital stock or securities at the
time issuable upon exercise of the Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, to receive any right to subscribe for or purchase any shares of capital stock of any class or any other
securities, or to receive any other security; (b) of any recapitalization or reorganization of the Company, any reclassification of the Common Stock of the Company, any amalgamation, conversion, consolidation or merger of the Company with or
into another person or entity, or sale, lease, license, transfer or conveyance of all or substantially all of the Company’s assets to another person or entity; or (c) of the voluntary or involuntary dissolution, liquidation or winding-up
of the Company; then, and in each such case, the Company shall send or cause to be sent to the Registered Holders at least 20 days prior to the applicable record date or the applicable expected effective date, as the case may be, for the event, a
written notice specifying, as the case may be, (i) the record date for such dividend, distribution, or other right, and a description of such dividend, distribution or other right to be taken at such meeting or by written consent, or
(ii) the effective date on which such reorganization, reclassification, amalgamation, conversion, consolidation, merger, sale, lease, license, transfer, conveyance, dissolution, liquidation or winding-up is proposed to take place, and the date,
if any is to be fixed, as of which the books of the Company shall close or a record shall be taken with respect to which the holders of record of Common Stock (or such other capital stock or securities at the time issuable upon exercise of the
Warrant) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other property deliverable upon such recapitalization, reorganization, reclassification, amalgamation, conversion,
consolidation or merger, sale, dissolution, liquidation or winding-up, and the amount per share and character of such exchange applicable to the Warrant and the shares of Common Stock issuable upon exercise of the Warrants. Failure to give such
notice, or any defect therein, shall not affect the legality or validity of such event. 

  
 10 

 4.7 No Fractional Shares. Notwithstanding any provision contained in this Agreement to the
contrary, the Company shall not issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to
receive a fractional interest in a share, the Company shall, upon such exercise, at its option either (a) round up to the nearest whole number, the number of shares of Common Stock to be issued to such holder or (b) in lieu of such
fractional share interests, pay to such holder an amount in cash equal to the product obtained by multiplying (i) the fractional share interest to which such holder would otherwise be entitled by (ii) the Fair Market Value on the exercise
date. 
 4.8 Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this
Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant to this Agreement; provided, however, that the
Company may at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or
substitution for an outstanding Warrant or otherwise, may be in the form as so changed. 
 4.9 Other Events. If any event shall occur
affecting the Company as to which none of the provisions of preceding subsections of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (a) avoid an adverse impact
on the Warrants, and (b) effectuate the intent and purpose of this Section 4, then the Board shall make an appropriate adjustment in the Warrant Price and the number of shares of Common Stock issuable upon exercise of the Warrants
so as to protect the rights of the Registered Holder in a manner consistent with the provisions of this Section 4; provided, that no such adjustment pursuant to this Section 4.8 shall increase the Warrant Price or
decrease the number of shares of Common Stock issuable as otherwise determined pursuant to this Section 4. 
 4.10 Other
Warrants. In no event will any adjustment, comparable to those in this Section 4, be made to the SPA Warrants unless such adjustment is made pursuant to this Section 4 on the same terms to all outstanding Warrants. The
immediately preceding sentence shall not be in limitation of, or otherwise affect, the other provisions of this Section 4. 
 5. Transfer and
Exchange of Warrants. 
 5.1 Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any
outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant
representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request. In
connection with any such transfer, upon reasonable request by the Company or the Warrant Agent to such transferring holder at the expense of such holder, such holder will give to the Company or the Warrant Agent, as applicable, an opinion of counsel
(which may be in-house counsel or outside counsel to such holder or its investment adviser) in form and substance reasonably satisfactory to the Company or the Warrant Agent, as applicable, to the effect that the proposed transfer of such Warrant
may be effected without registration or qualification of such Warrant under the Securities Act or any applicable state securities law. 

  
 11 

 5.2 Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent,
together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate
number of Warrants. 
 5.3 Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or
exchange which shall result in the issuance of a warrant certificate for a fraction of a warrant. 
 5.4 Service Charges. No service
charge shall be made for any exchange or registration of transfer of Warrants. 
 5.5 Warrant Execution and Countersignature. The
Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the
Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose. 
 6. Other Provisions Relating to
Rights of Holders of Warrants. 
 6.1 No Rights as Stockholder; Limitation on Liability. A Warrant does not entitle the Registered
Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends or other distributions (except as provided in Section 4), exercise any preemptive rights to vote or to
consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter. No provisions hereof, in the absence of affirmative action by the Registered Holder to purchase
shares of Common Stock, and no mere enumeration herein of the rights or privileges of any Registered Holder, shall give rise to any liability of any Registered Holder for the Warrant Price or as a stockholder of the Company, whether such liability
is asserted by the Company or by its creditors. 
 6.2 Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost,
stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their reasonable discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen,
mutilated, or destroyed Warrant shall be at any time enforceable by anyone. 
 6.3 Reservation of Common Stock. The Company shall at
all times reserve and keep available a number of its authorized but unissued Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement. 

6.4 No Impairment. The Company will not, by amendment of its governing documents or through any recapitalization, reclassification,
reorganization, amalgamation, conversion, merger, consolidation, or through any sale, lease, license, transfer, conveyance of its assets, or through any other similar transactions, or through any dissolution, liquidation, winding up of the Company
or through issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Agreement, but will at all times in good faith assist in the carrying out of all such terms and in
the taking of all such action as may be necessary or appropriate in order to protect the rights of the Registered Holders against 

  
 12 

 
impairment. Without limiting the generality of the foregoing, the Company (a) will not increase the par value of any shares of Common Stock issuable upon exercise of any Warrant above the
amount payable therefor on such exercise, (b) will take all such action as may be reasonably necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares Common Stock upon the exercise of
this Warrant, and (c) will not close its stockholder books or records in any manner which interferes with the timely exercise of this Warrant. 
 7.
Concerning the Warrant Agent and Other Matters. 
 7.1 Payment of Taxes. The Company shall from time to time promptly pay any
issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of Common Stock to the registered holder thereof upon the
exercise of the Warrants, including such taxes imposed pursuant to Section 3.3.1 hereof, but the Company shall not be obligated to pay any transfer taxes associated with transfers by any Registered Holder of the Warrants or the Common
Stock issuable upon exercise of any Warrants. 
 7.2 Resignation, Consolidation, or Merger of Warrant Agent. 

7.2.1 Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign
its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or
otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent; provided that any such successor Warrant Agent shall be a nationally recognized transfer agent that is registered as a “tranfer
agent” with the SEC pursuant to Section 17A(c) of the Exchange Act. Any such properly appointed successor Warrant Agent shall be deemed the “Warrant Agent” for all purposes hereunder. If the Company shall fail to make such
appointment within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or its Warrant(s) for
inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent,
whether appointed by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and
authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities,
duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent
shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent
the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and
obligations. 
 7.2.2 Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed,
the Company shall give notice thereof to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment. 

  
 13 

 7.2.3 Merger or Consolidation of Warrant Agent. Any corporation into which
the Warrant Agent may be merged or with which it may be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any
further act. 
 7.3 Fees and Expenses of Warrant Agent. 

7.3.1 Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant
Agent hereunder and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder. 

7.3.2 Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed,
executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement. 

7.4 Liability of Warrant Agent. 

7.4.1 Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent
shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed)
may be deemed to be conclusively proved and established by a statement signed by the President or Chairman of the Board and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith
by it pursuant to the provisions of this Agreement. 
 7.4.2 Indemnity. The Warrant Agent shall be liable hereunder
only for its own gross negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything done or
omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent’s gross negligence, willful misconduct or bad faith. 

7.4.3 Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with
respect to the validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The
Warrant Agent shall not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that
would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether
any Common Stock shall, when issued, be valid and fully paid and nonassessable. 
 7.5 Acceptance of Agency. The Warrant Agent hereby
accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and 

  
 14 

 
among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the
purchase of Common Stock through the exercise of the Warrants. 
 8. Miscellaneous Provisions. 

8.1 Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind
and inure to the benefit of their respective successors and assigns. The Company will not amalgamate, merge, convert or consolidate with or into, or sell, transfer, license or lease all or substantially all of its property or assets to, any other
party unless the successor, transferee, licencee or lessee party, as the case may be (if not the Company), assumes (expressly or by operation of law) the due and punctual performance and observance of each and every covenant and condition of this
Agreement and the Warrants to be performed and observed by the Company. Subject to the preceding sentence, nothing in this Agreement shall be construed to give to any person or entity other than the Company, each Registered Holder and each Electing
Holder any legal or equitable right, remedy or cause of action under this Agreement. 
 8.2 Notices. All notices, statements or other
documents which are required or contemplated by this Agreement or any Warrant (including, without limitation, the delivery of any Exercise Notice or notice of assignment (in the form attached to each Warrant), the surrender of any Warrant and the
issuance of any new Warrant) to be given, delivered or made by the Company, the Warrant Agent or any Holder (each, a “Notice”) shall be in writing and shall be: (a) delivered personally or by commercial messenger;
(b) sent via a recognized overnight courier service; (c) sent by registered or certified mail, postage pre-paid and return receipt requested; or (d) sent by facsimile transmission, provided confirmation of receipt is received by
sender and the original Notice is sent or delivered contemporaneously by an additional method provided in this Section 8.2; in each case so long as such Notice is addressed to the intended recipient thereof as set forth below: 

If to the Company: 
 EveryWare
Global, Inc. 
 519 North Pierce Avenue 

Lancaster, OH 43130 
 Attention:
Chief Executive Officer 
                  General
Counsel 
 Facsimile: 740-681-6455 

If to the Warrant Agent: 

Continental Stock Transfer & Trust Company 

17 Battery Place 
 New York, NY
10004 
 Attention: Compliance Department 

If to any Holder, at such address as is reflected in the records of the Warrant Agent for such Holder. 

  
 15 

 Any party may change its address specified above by giving each party Notice of such change in
accordance with this Section 8.2. Any Notice shall be deemed given upon actual receipt (or refusal of receipt). 
 8.3
Applicable Law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result
in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the
State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. 
 8.4 Persons Having Rights under this Agreement. Nothing in this Agreement
expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the Registered Holders of the Warrants any right,
remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and
exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants, each of whom are third party beneficiaries of this Agreement. 

8.5 Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the
Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit his, her or its Warrant(s) for inspection by it. 

8.6 Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

8.7 Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect
the interpretation thereof. 
 8.8 Amendments. This Agreement may be amended by the parties hereto without the consent of any
Registered Holder for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein. All other modifications or amendments, including any amendment to increase the Warrant Price, change the
number of shares of Common Stock issuable upon exercise of the Warrants or shorten the Exercise Period, shall require the written consent of the Registered Holders of then outstanding Warrants then exercisable into a majority of the shares of Common
Stock issuable upon exercise of all then outstanding Warrants. Notwithstanding the foregoing, the Company may extend the duration of the Exercise Period pursuant to Section 3.2 without the consent of the Registered Holders;
provided, however, that any such extension also shall be applicable on the same terms to all the SPA Warrants. Notwithstanding the foregoing, in the event that Monomoy Capital Partners, L.P. or any of its affiliates (including the
Company and its subsidiaries) (the “Affiliated Holders”) holds any Warrants, for purposes of any amendment, waiver or modification of this Agreement, all such Affiliated Holders will not have the right to consent to any
amendment, waiver or modification, but will be deemed to have consented in the same proportion as all other Registered Holders consenting on such matter. 

  
 16 

 8.9 Severability. This Agreement shall be deemed severable, and the invalidity or
unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties
hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 

8.10 Remedies. If the Company fails to perform, comply with or observe any covenant or agreement to be performed, complied with or
observed by it under this Agreement or any Warrant, any Registered Holder may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term contained in this Agreement or any Warrant or
for an injunction against the breach or threatened breach of any such term or in aid of the exercise of any power granted in this Agreement or any Warrant or to enforce any other legal or equitable right, or to take any one or more of such actions.
The Company hereby agrees that any Registered Holder shall not be required or otherwise obligated to, and hereby waives any right to demand that such Registered Holder, post any performance or other bond in connection with the enforcement of its
rights and remedies hereunder. The Company agrees to pay all reasonable fees, costs, and expenses, including, without limitation, fees and expenses of attorneys, accountants and other experts retained by any such Registered Holder, and all
reasonable fees, costs and expenses of appeals, incurred or expended by such Registered Holder in connection with the enforcement of this Agreement, any Warrant or the collection of any sums due hereunder, whether or not suit is commenced. None of
the rights, powers or remedies conferred under this Agreement and any Warrant shall be mutually exclusive, and each right, power or remedy shall be cumulative and in addition to any other right, power or remedy whether conferred by this Agreement or
any Warrant or now or hereafter available at law, in equity, by statute or otherwise. 

  
 17 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the
date first above written. 
  

			
	EVERYWARE GLOBAL, INC.
		
	 By:
	 	     /s/ Sam A. Solomon

		 	     Name: Sam A. Solomon

    Title:    Chief Executive Officer

  

			
	CONTINENTAL STOCK TRANSFER &
	 TRUST COMPANY, as Warrant Agent

		
	 By:
	 	     /s/ Michael G. Mullings

		 	     Name: Michael G. Mullings

    Title:   Vice President

  
 18 

 EXHIBIT A 

Specimen Warrant Certificate 

(See attached) 

  
 19 

 Exhibit A 

THIS SECURITY, AS WELL AS THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS SECURITY, AS WELL AS THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY, MAY NOT BE OFFERED FOR SALE, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED (I) IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, (II) IN THE ABSENCE OF AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS, AS EVIDENCED (IF REQUIRED BY THE COMPANY) BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT, OR (III) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER REPRESENTATION LETTER AND A BROKER REPRESENTATION LETTER, IN EITHER CASE AS MAY BE APPLICABLE) THAT THE SECURITIES MAY BE SOLD PURSUANT TO
SUCH RULE). NO REPRESENTATION IS MADE BY THE COMPANY AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT FOR RESALES OF THIS SECURITY, OR THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY 

EVERYWARE GLOBAL, INC. 

WARRANT 
  

	 Warrant No. 
	 Original Issue Dated: July 30, 2014 

Re-issuance Date:                     ,
20     
 EVERYWARE GLOBAL, Inc., a Delaware corporation (the “Company”), hereby certifies that,
for value received, [Name of Holder] or its registered assigns (the “Holder”), is the registered holder of warrants (the “Warrants”) to purchase
[                ] shares of common stock, $0.0001 par value per share (the “Common Stock”), of the Company. Each Warrant entitles the holder,
upon exercise during the period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and nonassessable shares of Common Stock as set forth below, at the exercise price (the “Exercise
Price” ) of $0.01 per share of Common Stock, payable in lawful money of the United States of America (or through “cashless exercise” as permitted by the Warrant Agreement) upon surrender of this Warrant
Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined
herein shall have the meanings given to them in the Warrant Agreement. In the event of a conflict between this Warrant and the Warrant Agreement, the terms of the Warrant Agreement shall prevail. 

Each Warrant is initially exercisable for one fully paid and non-assessable share of Common Stock. The number of shares of Common Stock
issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement. The initial Exercise Price per share of Common Stock for any Warrant is equal to $0.01 per share. The Exercise
Price is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement. Subject to the conditions set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent
not exercised by the end of such Exercise Period, such Warrants shall become void. 
 Reference is hereby made to the further provisions of
this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully set forth at this place. 

This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement. This
Warrant Certificate shall be governed and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof. 

 IN WITNESS WHEREOF, the following parties have executed this Warrant as of the date first above
written. 
  

									
	EVERYWARE GLOBAL, INC.	 		 	CONTINENTAL STOCK TRANSFER &
TRUST COMPANY
					
	By:	 	  
	 		 	By:	 	  

	Name:	 		 	Name:
	Its:	 		 	Its:

 EVERYWARE GLOBAL, INC. (WARRANT) 

The Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive
shares of Common Stock and are issued pursuant to a Warrant Agreement dated as of July 30, 2014 and as may be amended from time to time (the “Warrant Agreement”), duly executed and delivered by the Company to Continental
Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred
to for a description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder” meaning the
Registered Holders or Registered Holder) of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have the
meanings given to them in the Warrant Agreement. 
 Warrants may be exercised at any time during the Exercise Period set forth in the
Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together with payment
of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as permitted by the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any
exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the
number of Warrants not exercised. 
 Notwithstanding anything else in this Warrant Certificate or the Warrant Agreement, no Warrant may be
exercised unless either (A) exercised through a “cashless exercise” as permitted by the Warrant Agreement or (B) if not exercised pursuant to a “cashless exercise,” at the time of exercise:
either (i) a registration statement covering the shares of Common Stock to be issued upon exercise is effective under the Securities Act and a prospectus thereunder relating to the shares of Common Stock is current; or (ii) the
issuance such shares is exempt from registration under the federal securities laws and the securities laws of the state of residence of the holder. 

The Warrant Agreement provides that upon the occurrence of certain events the number of the Warrants set forth on the face hereof may, subject
to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise, at its option either (i) round up to the
nearest whole number of shares of Common Stock to be issued to the holder of the Warrant or (ii) pay cash in lieu of such fractional interest. 

Warrant Certificates, when surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person
or by legal representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or
Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants. 
 Upon due presentation (i) for registration
of transfer of this Warrant Certificate at the office of the Warrant Agent and (ii) of the assignment form set forth hereon properly completed and executed, a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the
aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge, except for any transfer tax imposed in connection with
the transfer by the Registered Holder thereof. 
 The Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as
the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all other purposes,
and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company. 

 ELECTION TO PURCHASE 

(To Be Executed Upon Exercise of Warrants) 

The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive
                 shares of Common Stock and herewith tenders payment for such shares to the order of EveryWare Global, Inc. (the “Company”) in
the amount of $         in accordance with the terms hereof. The undersigned requests that a certificate for such shares be registered in the name of: 

 

	
	                                      
                                         
                                         
                                         
                                         
                                         
              
	
	whose address is                                  
                                         
                                         
                                         
                                         
                           

  

	
	and that such shares be delivered to:                           
                                         
                                         
                                         
                                      

  

	
	whose address is                                  
                                         
                                         
                                         
                                         
                           

 If said number of shares is less than all of the shares of Common Stock purchasable hereunder, the undersigned requests that a
new Warrant Certificate representing the remaining balance of such shares be registered in the name
of                                        
                  
  

	
	whose address is                                  
                                         
                                         
                                         
                                         
                           

  

	
	and that such Warrant Certificate be delivered to:                        
                                         
                                         
                                         
                

  

	
	whose address is                                  
                                         
                                         
                                         
                                         
                           

 In the event that the Warrant is to be exercised on a “cashless basis” pursuant to the
Warrant Agreement, (i) the number of shares that this Warrant is exercisable for shall be determined in accordance with the Warrant Agreement and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably
elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive shares of Common Stock. If said number of shares is less than all of the shares of Common Stock
purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares be registered in the name
of                         . 
  

	
	whose address is                                  
                                         
                                         
                                         
                                         
                           

  

	
	and that such Warrant Certificate be delivered to:                        
                                         
                                         
                                         
                

  

	
	whose address is                                  
                                         
                                         
                                         
                                         
                           

 In the event that the Warrant is to be exercised by paying the Warrant Price in cash pursuant to the Warrant
Agreement, the undersigned confirms that (by checking each below): 
  

	    	It is an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933, as amended (the “Securities Act”)), and hereby confirms to the
Warrant Agent each of the following representations and agreements are true as of the date hereof (by checking each that applies to the undersigned): 

     It either alone or together with its representatives has such knowledge, sophistication and experience in
business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Warrant, and has so evaluated the merits and risks of such investment; 

      It will not offer or sell the Warrant by any form of general
solicitation or general advertising, including but not limited to the methods described in Rule 502(c) under the Securities Act; 

     It understands that the Warrant is characterized as “restricted security” under the U.S. federal
securities laws inasmuch as it is being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Securities Act only
in certain limited circumstances; and 
      It is understood that certificates evidencing the Warrant will bear
any legend as required by the Blue Sky laws of any state and a restrictive legend in substantially the form set forth in the Warrant Agreement (as defined in the Warrant Certificate). 

Unless the foregoing items are checked, the Warrant Agent may refuse to permit the exercise of any Warrants evidenced by this certificate other than on
a “cashless basis”; provided, however, that if the foregoing items are checked, the Company or the Warrant Agent may require, prior to permitting any such exercise of this Warrant on other than a
“cashless basis”, in their reasonable discretion, such written legal opinions, certifications and other information as the Warrant Agent or the Company has reasonably requested to confirm that such exercise is being made
pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. 
  

			
		  	  

	Dated:                     , 20    .	  	Signature(s)
		
		  	  

		  	(Address)
		
		  	  

		  	(Social Security or Taxpayer Identification Number(s))
		
	  
	  	
	Signature(s) Guaranteed	  	

 IN THE EVENT THE NUMBER OF SHARES FOR WHICH THIS WARRANT IS BEING EXERCISED IS LESS THAN ALL OF THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER, AND THE UNDERSIGNED HAS REQUESTED THAT A NEW WARRANT CERTIFICATE REPRESENTING THE REMAINING BALANCE OF SUCH SHARES BE REGISTERED IN THE NAME OF PERSON OTHER THAN THE RECORD HOLDER OF THIS WARRANT, THE SIGNATURE(S) ABOVE MUST
BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17AD-15). 

 ASSIGNMENT FORM 

FOR VALUE RECEIVED, the undersigned registered holder of the within Warrant hereby sells, assigns and transfers unto
                    , whose address is
                            , all of the rights of the undersigned under the within Warrant, with respect to
                 shares of Common Stock of EVERYWARE GLOBAL, INC. and, if such shares of Common Stock shall not include all the shares of Common Stock issuable as
provided in the within Warrant, that a new Warrant of like tenor for the shares not being transferred hereunder be issued in the name of
                                          and
delivered to [choose one by circling the applicable letter] (a) the undersigned or (b)                     , whose address is
                            , and does hereby irrevocably constitute and appoint Continental Stock
Transfer & Trust Company as Attorney to register such transfer on the books of EVERYWARE GLOBAL, INC. maintained for the purpose, with full power of substitution in the premises. 

 

					
	Dated:                                     
                                         
                            	  		  	[                             ]
			
		  		  	By:                                     
                                         
                             
		  		  	(Signature of Registered Holder)
			
	Dated:                                     
                                         
                            	  	Signed:	  	                                     
                                         
                                    
		  		  	 (Sign exactly as name appears on the other side of

this Warrant)

 In connection with any transfer of this Warrant, the undersigned confirms that it has not utilized any general
solicitation or general advertising in connection with the transfer and is making the transfer pursuant to one of the following: 
 [Check
One] 
  

			
	(1)         	 	to the Company; or
		
	(2)         	 	to an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933, as amended (the “Securities Act”)) that has furnished to the Warrant Agent a signed
letter containing certain representations and agreements (the form of which letter can be obtained from the Warrant Agent); or
		
	(3)         	 	pursuant to the exemption from registration provided by Rule 144 under the Securities Act or pursuant to another exemption available under the Securities Act; or
		
	(4)         	 	Pursuant to an effective registration statement under the Securities Act.

 and unless the box below is checked, the undersigned confirms that such Warrant is not being transferred to an
“affiliate” of the Company as defined in Rule 144 under the Securities Act (an “Affiliate”): 
  

	 	 ̈	The transferee is an Affiliate of the Company. 

 Unless one of the foregoing items (1) through (4) is checked, the Warrant Agent may
refuse to register any Warrants evidenced by this certificate in the name of any person other than the registered Holder thereof; provided, however, that if item (2) or (3) is checked, the Company or the Warrant Agent may
require, prior to registering any such transfer of this Warrant, in their reasonable discretion, such written legal opinions, certifications (including an investment letter in the case of box (2) or (3)) and other information as the
Warrant Agent or the Company has reasonably requested to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. 

 

					
			
	Dated:                                     
                                         
                            	  	Signed:	  	  

		  		  	(Sign exactly as name appears on the other side of this Warrant)
			
	  
	  		  	
	Signature(s) Guaranteed	  		  	

 THE SIGNATURE(S) ABOVE MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN
ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17AD-15). 

 EXHIBIT B 

Notice and Questionnaire 

The undersigned beneficial holder of warrants (“Warrants”) to purchase common stock, par value $0.0001 (the “Common
Stock”), of EveryWare Global, Inc. (the “Company”) understands that the Company intends to file or has filed with the Securities and Exchange Commission a registration statement (the “Shelf Registration Statement”) for the
registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Common Stock issuable under the Warrants (“Registrable Securities”), in accordance with the terms of the warrant
agreement (the “Warrant Agreement”), among the Company and Continental Stock Transfer & Trust Company, as Warrant Agent. A copy of the Warrant Agreement is available from the Company upon request at the address set forth below.
All capitalized terms not otherwise defined herein shall have the meaning ascribed thereto in the Warrant Agreement. 
 In order to sell, or
otherwise dispose of, any Registrable Securities pursuant to the Shelf Registration Statement, a holder of Warrants or Registrable Securities generally will be required to be named as a selling securityholder in the related prospectus, and deliver a
prospectus to purchasers of Registrable Securities. Holders of Warrants or Registrable Securities that do not complete this Notice and Questionnaire and deliver it to the Company as provided below will not be named as selling securityholders in the
prospectus and, therefore, will not be permitted to sell any Registrable Securities pursuant to the Shelf Registration Statement. 
 Certain
legal consequences arise from being named as a selling securityholder in the Shelf Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities
law counsel regarding the consequences of being named or not being named as a selling securityholder in the Shelf Registration Statement and the related prospectus. 

NOTICE 
 The undersigned
beneficial owner (the “Selling Securityholder”) of Registrable Securities hereby gives notice to the Company of its intention to sell or otherwise dispose of Registrable Securities beneficially owned by it and listed below in
Item 3 (unless otherwise specified under such Item 3) pursuant to the Shelf Registration Statement. The undersigned, by signing and returning this Notice and Questionnaire, understands that it will be bound by the terms and conditions of
this Notice and Questionnaire. 
 QUESTIONNAIRE 

Please respond to every item, even if your response is “none.” If you need more space for any response, please attach additional
sheets of paper. Please be sure to indicate your name and the number of the item being responded to on each such additional sheet of paper, and to sign each such additional sheet of paper before attaching it to this Questionnaire. Please note that
you may be asked to answer additional questions depending on your responses to the following questions. 
 If you have any questions about
the contents of this Questionnaire or as to who should complete this Questionnaire, please contact the Erika Schoenberger of the Company at telephone number: (740) 681-6417 or Carol Anne Huff of Kirkland & Ellis LLP at
(312) 862-2163. 
 The undersigned hereby provides the following information to the Company and represents and warrants that such
information is accurate and complete: 
  

	 	1.	Identity and Background as the holder of Warrants or Registrable Securities. 

(a) Full legal name of holder of Warrants or Registrable Securities: 

  
 27 

 (b) Business address of holder of Warrants or Registrable Securities (including
street address) (or residence if no business address), telephone number and facsimile number: 
 Address: 

Telephone No.: 

Fax No.: 

(c) Are you a broker-dealer registered pursuant to Section 15 of the Exchange Act? 

 

	 	 ̈	Yes 

	 	 ̈	No 

 (d) If your response to Item 1(c) above is no, are you an
“affiliate” of a broker-dealer registered pursuant to Section 15 of the Exchange Act? 
  

	 	 ̈	Yes 

	 	 ̈	No 

 For the purposes of this Item 1(d), an “affiliate” of a registered broker-dealer
includes any person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such broker-dealer, and does not include any individuals employed by such broker-dealer or its
affiliates. 
  

	 	2.	Relationship with the Company. 

 (a) Have you or any of your
affiliates, officers, directors or principal equity holders (owners of 5% or more of the equity securities of the undersigned) held any position or office or have you had any other material relationship with the Company (or its predecessors or
affiliates) within the past three years? 
  

	 	 ̈	Yes 

	 	 ̈	No 

 (b) If your response to Item 2(a) above is yes, please state the
nature and duration of your relationship with the Company: 
  

	 	3.	Interest in the Registrable Securities. 

 (a) State whether you
are a record holder of Warrants or Registrable Securities and the amount of each beneficially owned by you: 
 (b) Other than
as set forth in your response to Item 3(a) above, do you beneficially own any other securities of the Company? 
  

	 	 ̈	Yes 

	 	 ̈	No 

  
 28 

 (c) If your answer to Item 3(b) above is yes, state the type, the aggregate
amount and CUSIP No. of such other securities of the Company beneficially owned by you: 
 Type: 

Aggregate amount: 

CUSIP No.: 

(d) Did you acquire the securities listed in Item 3(a) above in the ordinary course of business? 

 

	 	 ̈	Yes 

	 	 ̈	No 

 (e) At the time of your purchase of the securities listed in Item 3(a)
above, did you have any agreements or understandings, direct or indirect, with any person to distribute the securities? 
  

	 	 ̈	Yes 

	 	 ̈	No 

 (f) If your response to Item 3(e) above is yes, please describe such
agreements or understandings: 
  

	 	4.	Nature of your Beneficial Ownership. 

 (a) Check if the beneficial
owner set forth in your response to Item 1(a) is any of the below: 
 (i) A reporting company under the Exchange Act.  ̈ 
 (ii) A majority-owned subsidiary of a reporting company under the Exchange
Act.  ̈ 
 (iii) A registered investment fund under the 1940 Act.  ̈ 
 (b) If the beneficial owner of the Registrable Securities set forth in your
response to Item 1(a) above is a limited partnership, state the names of the general partner(s) of such limited partnership: 

(i) With respect to each general partner listed in Item 4(b) above who is not a natural person and is not publicly-held,
name each shareholder (or holder of partnership interests, if applicable) of such general partner. If any of these named shareholders are not natural persons or publicly-held entities, please provide the same information. This process should be
repeated until you reach natural persons or a publicly-held entity. 
 (c) Name your controlling shareholder(s) (the
“Controlling Entity”). If the Controlling Entity is not a natural person and is not a publicly-held entity, name each shareholder of such Controlling Entity. If any of these named shareholders are not natural persons or publicly-held
entities, please provide the same information. This process should be repeated until you reach natural persons or a publicly-held entity. 

  
 29 

 (i) (A) Full legal name of Controlling Entity(ies) or natural person(s) who
has/have sole or shared voting or dispositive power over the Registrable Securities: 
 (B) Business address (including
street address) (or residence if no business address), telephone number and facsimile number of such person(s): 
 Address: 

Telephone No.: 
 Fax No.: 

(C) Name of shareholders: 

(ii) (A) Full legal name of Controlling Entity(ies): 

(B) Business address (including street address) (or residence if no business address), telephone number and facsimile number
of such person(s): 
 Address: 

Telephone No.: 
 Fax No.: 

(iii) Name of shareholders: 
  

	 	5.	Plan of Distribution. 

 Except as set forth below, the undersigned Selling
Securityholder intends to distribute the Registrable Securities listed above in Item (3) only as follows (if at all): All or any portion of such Registrable Securities may be sold from time to time directly by the undersigned Selling
Securityholder or, alternatively, through one or more underwriters, broker-dealers or agents. Such Registrable Securities may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of sale, at varying
prices determined at the time of sale, or at negotiated prices. Such sales may be effected in transactions (which may involve crosses or block transactions) (i) on any national securities exchange or quotation service on which the
Registrable Securities may be listed or quoted at the time of sale, (ii) in the over-the-counter market, (iii) in transactions otherwise than on such exchanges or services or in the over-the-counter market, or (iv) through the writing
of options, whether such options are listed on an options exchange or otherwise, (v) ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers, (vi) block trades in which the broker-dealer will attempt
to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction, (vii) purchases by a broker-dealer as principal and resale by the broker-dealer for its account, (viii) an exchange
distribution in accordance with the rules of the applicable exchange, (ix) privately negotiated transactions, (x) short sales, (xi) sales pursuant to Rule 144, (xii) broker-dealers may agree with the selling securityholder to
sell a specified number of shares at a stipulated price per share, (xiii) a combination of any such methods of sale, and (xiv) any other method permitted pursuant to applicable law. In connection with sales of the Registrable
Securities or otherwise, the Selling Securityholder may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the Registrable Securities in the course of hedging the positions they assume. The Selling
Securityholder may also sell Registrable Securities short and deliver Registrable Securities to close out such short positions, or loan or pledge Registrable Securities to broker-dealers that in turn may sell such Registrable Securities. 

  
 30 

 State any exceptions here: 

Note: In no event will such method(s) of distribution take the form of an underwritten offering of the Registrable Securities without the
prior written agreement of the Company. 
 The undersigned acknowledges its obligation to comply with the provisions of the Exchange Act and
the rules thereunder relating to stock manipulation, particularly Regulation M thereunder (or any successor rules or regulations), in connection with any offering of Registrable Securities. The undersigned agrees that neither it nor any person
acting on its behalf will engage in any transaction in violation of such provisions. 
 In accordance with the undersigned’s obligation
under the Warrant Agreement to provide such information as may be required by law for inclusion in the Shelf Registration Statement, the undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided
herein that may occur subsequent to the date hereof at any time while the Shelf Registration Statement remains effective and the undersigned still holds Registrable Securities. 

The undersigned acknowledges the Company may require the undersigned to furnish to the Company, in addition to the information provided
herein, such information regarding the undersigned and the intended distribution of the shares of Common Stock issuable upon exercise of the Warrant and such other information as the Company may from time to time reasonably request in writing in
connection with the registration pursuant to the Shelf Registration Statement. 
 All notices to the beneficial owner hereunder and pursuant
to the Warrant Agreement shall be made in writing to the undersigned at the address set forth in Item 1(b) of this Notice and Questionnaire. 

By signing below, the undersigned acknowledges that it is the beneficial owner of the Registrable Securities set forth herein, represents that
the information provided herein is accurate, and consents to the disclosure of the information contained in this Notice and Questionnaire and the inclusion of such information in the Shelf Registration Statement and the related prospectus. The
undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Shelf Registration Statement and the related prospectus. 

Once this Notice and Questionnaire is executed by the undersigned beneficial owner and received by the Company, the terms of this Notice and
Questionnaire, and the representations and warranties contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable by the respective successors, heirs, personal representatives and assigns of the Company and the
undersigned beneficial owner. This Notice and Questionnaire shall be governed in all respects by the laws of the State of New York, without giving effect to rules governing the conflict of laws. 

  
 31 

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Notice and
Questionnaire to be executed and delivered either in person or by its duly authorized agent. 
  

	
	RECORD OWNER OF WARRANTS OR REGISTRABLE SECURITIES:
	
	                                      
                                         
                        
	(Please Print)
	
	Signature:                                    
                                         
      
	
	Date:                                     
                                         
              

 PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE 

TO EVERYWARE GLOBAL, INC. AS FOLLOWS: 

EveryWare Global, Inc. 
 519 North
Pierce Avenue 
 Lancaster, Ohio 43130 

Telecopy: (740) 681-6455 

Attention: General Counsel 
 This Notice and
Questionnaire must be returned within fifteen (15) days after receipt of the Company’s notice with respect to the filing of a Shelf Registration Statement pursuant to Section 2.5 of the Warrant Agreement in order to include Warrants
in such Shelf Registration Statement. 

  
 32EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 

SECURITIES PURCHASE AGREEMENT 

among 
 EveryWare
Global, Inc. and 
 the Investors identified on the signature pages hereto 

Dated as of July 30, 2014 

 TABLE OF CONTENTS 

 

									
	 	  	Page	 
	1.	 	Definitions; Rules of Construction	  	 	2	  
			
	2.	 	Preferred Shares and Warrants; Purchase Price; Closing	  	 	9	  
			
	3.	 	Additional Closing Deliverables	  	 	9	  
				
	3.1.	 		  	Listing Approval	  	 	10	  
	3.2.	 		  	Loan Amendments	  	 	10	  
	3.3.	 		  	COD	  	 	10	  
	3.4.	 		  	Registration Rights Agreement	  	 	10	  
	3.5.	 		  	Fees and Expenses	  	 	10	  
	3.6.	 		  	Financial Projections	  	 	10	  
			
	4.	 	Representations and Warranties of the Company	  	 	10	  
				
	4.1.	 		  	Organization and Qualification	  	 	10	  
	4.2.	 		  	Authorization; Enforcement	  	 	10	  
	4.3.	 		  	No Conflicts	  	 	11	  
	4.4.	 		  	Securities	  	 	11	  
	4.5.	 		  	Capitalization	  	 	12	  
	4.6.	 		  	SEC Reports; Financial Statements	  	 	12	  
	4.7.	 		  	Solvency	  	 	13	  
	4.8.	 		  	No General Solicitation; Placement Agent’s Fees	  	 	13	  
	4.9.	 		  	Private Placement; Investment Company	  	 	13	  
	4.10.	 		  	Bad Actor	  	 	14	  
	4.11.	 		  	Consents	  	 	14	  
	4.12.	 		  	Compliance	  	 	14	  
	4.13.	 		  	Internal Accounting Controls	  	 	14	  
	4.14.	 		  	Sarbanes-Oxley Act	  	 	15	  
	4.15.	 		  	Reliance by the Investors	  	 	15	  
	4.16.	 		  	Subsidiary Rights	  	 	15	  
	4.17.	 		  	Proceedings Related to Transactions	  	 	15	  
			
	5.	 	Representations and Warranties of the Investors	  	 	15	  
				
	5.1.	 		  	Organization; Authority	  	 	15	  
	5.2.	 		  	No Public Sale or Distribution	  	 	15	  
	5.3.	 		  	Investor Status	  	 	16	  
	5.4.	 		  	General Solicitation	  	 	16	  
	5.5.	 		  	Experience of Each Investor	  	 	16	  
	5.6.	 		  	Access to Information	  	 	16	  
	5.7.	 		  	No Governmental Review	  	 	16	  

  
 i 

									
	 	  	Page	 
	5.8.	 		  	No Conflicts	  	 	17	  
	5.9.	 		  	Prohibited Transactions; Confidentiality	  	 	17	  
	5.10.	 		  	Restricted Securities	  	 	17	  
	5.11.	 		  	Legends	  	 	17	  
	5.12.	 		  	Residency	  	 	17	  
	5.13.	 		  	Bad Actor	  	 	17	  
	5.14.	 		  	No Additional Representations or Warranties	  	 	18	  
			
	6.	 	Restrictions on Transfer	  	 	18	  
				
	6.1.	 		  	Securities Restrictive Legends	  	 	18	  
	6.2.	 		  	Notice of Transfer; Opinions of Counsel	  	 	19	  
			
	7.	 	Covenants and Other Agreements	  	 	19	  
				
	7.1.	 		  	Shares Issuable Upon Exercise	  	 	19	  
	7.2.	 		  	Issuance and Voting Limits	  	 	20	  
	7.3.	 		  	The Stockholder Meeting	  	 	20	  
	7.4.	 		  	No Commitment for Additional Financing	  	 	20	  
	7.5.	 		  	Form D; Blue Sky laws	  	 	21	  
	7.6.	 		  	Reporting Status	  	 	21	  
	7.7.	 		  	Register of Preferred Shares and Warrants	  	 	21	  
	7.8.	 		  	No Amendment to Lender Warrant Agreement	  	 	21	  
	7.9.	 		  	Listing of Warrant Shares	  	 	21	  
	7.10.	 		  	Certain Transactions	  	 	22	  
	7.11.	 		  	Corporate Opportunities	  	 	22	  
			
	8.	 	Termination	  	 	22	  
			
	9.	 	Miscellaneous	  	 	22	  
				
	9.1.	 		  	Public Communications	  	 	22	  
	9.2.	 		  	Fees and Expenses	  	 	22	  
	9.3.	 		  	Indemnification	  	 	22	  
	9.4.	 		  	Releases	  	 	23	  
	9.5.	 		  	Entire Agreement	  	 	24	  
	9.6.	 		  	Notices	  	 	24	  
	9.7.	 		  	Amendments; Waivers	  	 	25	  
	9.8.	 		  	Successors and Assigns	  	 	25	  
	9.9.	 		  	No Third-Party Beneficiaries	  	 	25	  
	9.10.	 		  	Governing Law; Venue; Waiver of Jury Trial	  	 	26	  
	9.11.	 		  	Survival	  	 	26	  
	9.12.	 		  	Execution	  	 	26	  
	9.13.	 		  	Severability	  	 	26	  
	9.14.	 		  	Replacement of Stock Certificates	  	 	26	  

  
 ii 

									
	 	  	Page	 
	9.15.	 		  	Remedies	  	 	27	  
	9.16.	 		  	Payment Set Aside	  	 	27	  
	9.17.	 		  	Adjustments in Share Numbers and Prices	  	 	27	  
	9.18.	 		  	Acknowledgement	  	 	27	  

  

			
		 	Exhibits
		
	Exhibit A	 	Certificate of Designation
		
	Exhibit B	 	Form of Warrant
		
	Exhibit C	 	Company Certificate
		
	Exhibit D	 	Company Secretary’s Certificate
		
	Exhibit E	 	Investor Certificate
		
		 	Schedules
		
	Schedule 4.5	 	Capitalization
		
	Schedule 4.11	 	Consents
		
	Schedule 5.3	 	Broker-Dealer Affiliations

  
 iii 

 SECURITIES PURCHASE AGREEMENT 

THIS SECURITIES PURCHASE AGREEMENT dated as of July 30, 2014 (this “Agreement”), is among EveryWare Global, Inc.,
a Delaware corporation (the “Company”) and each investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors”). Unless
otherwise defined, capitalized terms used in this Agreement are defined in Section 1(a). 
 WHEREAS, the Company
and the Investors are each executing and delivering this Agreement in reliance upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act or Rule 506 of Regulation D as promulgated by the SEC under the Securities Act
(“Regulation D”); 
 WHEREAS, the Company has authorized the creation of Series A
Preferred Stock, par value $0.0001 per share (the “Preferred Stock”), having the rights, restrictions, privileges and preferences set forth in the form of the Certificate of Designation of Series A Preferred Stock, attached
as Exhibit A hereto (the “COD”); 
 WHEREAS, the Company has authorized the
creation of warrants, in substantially the form attached hereto as Exhibit B (the “Warrants”), to purchase a number of shares (as exercised, the “Warrant Shares”) of the Company’s common
stock, par value $0.0001 per share (the “Common Stock”), which, at the time of the Closing, shall represent 15% of the total number of shares of Common Stock outstanding on the Closing Date (assuming the exercise of the
Solomon Options, all the Warrants and all the warrants (the “Lender Warrants”) issued to the Company’s term lenders in connection with the Loan Amendments pursuant to the Warrant Agreement dated as of July 30, 2014,
between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Lender Warrant Agreement”); 

WHEREAS, the Company desires to issue and sell to each Investor, and such Investor desires to purchase from the Company, upon
the terms and subject to the conditions stated in this Agreement, that number of shares of Preferred Stock set forth on such Investor’s signature page to this Agreement (the “Preferred Shares”) and Warrants exercisable
for that number of Warrant Shares set forth on such Investor’s signature page to this Agreement (such Warrants, the Preferred Shares and the Warrant Shares, collectively being called herein the “Securities”);

 WHEREAS, prior to or contemporaneously with the execution and delivery of this Agreement, Waiver and Amendment
No. 1 dated as of July 30, 2014, to the Term Loan Agreement dated as of May 21, 2013, among Anchor Hocking, LLC, Oneida Ltd., Universal Tabletop, Inc., Deutsche Bank Securities Inc., Jefferies Finance LLC Deutsche Bank AG,
New York Branch and various lenders from time to time party thereto (the “Term Loan Amendment”), has been entered into; 

WHEREAS, prior to or contemporaneously with the execution and delivery of this Agreement, Amendment No. 6 dated as of
July 30, 2014, to the Second Amended and Restated Loan and Security Agreement dated as of May 21, 2013, among Oneida Ltd., Anchor Hocking, LLC, Universal Tabletop, Inc., Wells Fargo Bank, National Association and the other parties thereto
(the “ABL Amendment” and, together with the Term Loan Amendment, the “Loan Amendments”), has been entered into; and 

 WHEREAS, prior to or contemporaneously with the execution and delivery of this
Agreement, the Company, the Investors and the other parties thereto have executed and delivered an amendment to that certain Amended and Restated Registration Rights Agreement dated as of May 21, 2013, among the Company and the investors party
thereto (as amended, the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide certain registration rights with respect to the Warrant Shares under the Securities Act and the rules and
regulations promulgated thereunder, and applicable state securities laws; 
 NOW, THEREFORE, IN CONSIDERATION of the mutual
covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the Company and each of the Investors respectively agree as follows: 

1. Definitions; Rules of Construction. 

(a) As used herein the following terms have the following respective meanings: 

“ABL Amendment” has the meaning set forth in the recitals. 

“Affiliate,” means any Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 144 under the Securities Act. The term “control” (including, with correlative meanings, the terms “controlled by”
and “under common control with”), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting
securities or other ownership interest, by contract or otherwise. 
 “Agreement” has the
meaning set forth in the preamble, as amended or supplemented from time to time, together with any exhibits, schedules, appendices or other attachments thereto. 

“Associated Persons” means, with respect to any Person, (i) any Affiliate of such Person,
(ii) each of the current and former officers, directors, managers, principals, stockholders, members, trustees, partners, other equity owners, employees, financial advisors, attorneys, consultants, representatives, agents, advisory board
members, management companies, fund advisors and co-investment funds of such Person or any Affiliate of such Person, in each case, solely in its, his or her capacity as such, and (iii) with respect to each of the foregoing, each of their
respective predecessors, successors, assigns, heirs, executors and estates. 
 “Board of Directors”
means the board of directors of the Company. 
 “Business Day” means any day that is not a Saturday,
Sunday or other day in which banks are not required or authorized to be closed in New York City, New York. 

  
 2 

 “By-laws” means the by-laws of the Company, as amended to date and
presently in effect. 
 “Charter” means the Third Amended and Restated Certificate of Incorporation of
the Company, as amended to date and presently in effect. 
 “Charter Documents” has the meaning set
forth in Section 4.1. 
 “Claims” means all proceedings, causes of action, investigations,
debts, dues, sums of money, accounts, reckonings, bonds, bills, covenants, contracts, specialties, controversies, agreements, promises, variances, trespasses, damages, judgments, obligations, suits, costs, rights, remedies, compensation, expenses,
extents, executions, claims, liabilities (including claims for violations of federal or state securities laws and claims for recharacterization or subordination, gross negligence, fraudulent conveyance, torts, demands and other relief), and
liabilities of every kind and nature whatsoever, whether known or unknown, past, present or future, foreseen or unforeseen, liquidated or unliquidated, fixed or contingent, matured or unmatured, accrued or unaccrued, whether direct, indirect or
derivative, existing or hereafter arising, in law, equity or otherwise. 
 “Closing” has the meaning
set forth in Section 2.3. 
 “Closing Date” means the date and time of the Closing of the
purchase and sale of the Preferred Shares and the Warrants, which shall occur on the date hereof. 

“COD” has the meaning set forth in the recitals. 

“Code” means the Internal Revenue Code of 1986, as amended (or any successor statute). 

“Common Stock” has the meaning set forth in the recitals. 

“Company” has the meaning set forth in the preamble. 

“Company Certificate” has the meaning set forth in Section 2.4(c). 

“Company Covered Person” means, with respect to the Company as an “issuer” for purposes of
Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1). 

“Company Parties” means the Company, Anchor Hocking, LLC, Oneida Ltd., Universal Tabletop, Inc., and any
other Subsidiaries of the Company that are party to any of the Transaction Documents. 
 “Company
Released Claims” means, with respect to any Company Released Party, any and all Claims against such Company Released Party that directly or indirectly relate to (i) any Investor Released Party, (ii) such Company Released
Party’s relationship, responsibilities, actions or omissions with any Investor Released Party (whether as a stockholder, member, partner, other equity owner, manager, lender, agent for a lender, director, officer, employee or otherwise), or
(iii) such Company Released Party’s operation of the business of (or payments,  

  
 3 

 
distributions or dividends previously made to or received from) the Investor Released Parties, in each case that arise out of, relate to or are otherwise based on, any acts, omissions, facts,
matters, transactions or occurrences as of or prior to the Closing Date, regardless of whether such Company Released Claims are discovered after the Closing Date; provided, however, that Investor Released Claims will not include any
rights of any Investor or any Investor Released Party under any of the Transaction Documents. 
 “Company Released
Parties” means the Company and its Affiliates, and each of their respective predecessors, successors, assigns and Associated Persons; provided, however, that the definition of “Affiliate,” for the purposes of
this definition (including in the definition of Associated Persons for purposes of this definition) shall not include any Investor or any of its Affiliates other than the Company, any of its Subsidiaries and its and any of their controlled
Affiliates. 
 “Company Secretary’s Certificate” has the meaning set forth in Section
2.4(d). 
 “Contingent Obligation” means, as to any Person, any direct or indirect liability,
contingent or otherwise, of that Person with respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide
assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with
respect thereto. 
 “Convertible Securities” means (i) any rights, options or
warrants to acquire Common Stock or any other capital stock of the Company or any Subsidiary of the Company (including the Warrants and the Lender Warrants), and (ii) any notes, debentures, shares of preferred stock or other securities or
rights that are convertible or exercisable into, or exchangeable for, Common Stock or any capital stock of the Company or any Subsidiary of the Company. 

“Disqualification Event” means a “bad actor” disqualifying event described in Rule
506(d)(1)(i)-(viii) of the Securities Act. 
 “Exchange Act” means the Securities Exchange Act of
1934, as amended. 
 “Fees Due Upon Issuance” means $855,546.06. 

“FINRA” has the meaning set forth in Section 5.3. 

“GAAP” has the meaning set forth in Section 4.6(b). 

“Illegal Transfer Notice” has the meaning set forth in Section 6.2. 

“Indebtedness” of any Person means, without duplication (A) all indebtedness for borrowed money,
(B) all obligations issued, undertaken or assumed as the deferred purchase price of property or services (other than trade payables entered into in the ordinary course of business), (C) all reimbursement or payment obligations with respect
to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or  

  
 4 

 
similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all indebtedness created or arising under any
conditional sale or other title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank under
such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which, in connection with generally accepted accounting principles, consistently
applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or
otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such assets or
property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect of any indebtedness or obligations of any third party of the kinds referred to in clauses (A) through
(G) above. 
 “Insolvent” has the meaning set forth in Section 4.7. 

“Investor” has the meaning set forth in the preamble. 

“Investor Certificate” has the meaning set forth in Section 2.3(b). 

“Investor Released Claims” means, with respect to any Investor Released Party, any and all Claims
against such Investor Released Party that directly or indirectly relate to (i) any Company Party, (ii) such Investor Released Party’s relationship, responsibilities, actions or omissions (whether as a stockholder, member, partner,
other equity owner, manager, lender, agent for a lender, director, officer, employee or otherwise) with any Company Party, or (iii) such Investor Released Party’s ownership and operation of the business of (or payments, distributions or
dividends previously made to or received from) the Company Parties, in each case that arise out of, relate to or are otherwise based on, any acts, omissions, facts, matters, transactions or occurrences as of or prior to the Closing Date, regardless
of whether such Investor Released Claims are discovered after the Closing Date; provided, however, that Investor Released Claims will not include any rights of any Company Party or any Company Released Party under any of the
Transaction Documents. 
 “Investor Released Parties” means the Investors and their
Affiliates (including their affiliated funds), and each of their respective predecessors, successors, assigns and Associated Persons; provided, however, that the definition of “Affiliate,” for the purposes of this definition
(including in the definition of Associated Persons for purposes of this definition), none of the Company and its Subsidiaries shall be deemed to be an Affiliate of any Investor. 

“Lender Warrants” has the meaning set forth in the recitals. 

“Lender Warrant Agreement” has the meaning set forth in the recitals. 

“Lien” means any mortgage, lien (statutory or otherwise), charge, pledge, hypothecation, conditional
sales agreement, adverse claim, title retention agreement or other security interest,  

  
 5 

 
encumbrance or other title defect in or on any interest or title of any vendor, lessor, lender or other secured party to or of such Person under any conditional sale, trust receipt or other title
retention agreement with respect to any Property or asset of such Person. 
 “Liquidation Value” has the meaning set
forth in the COD. 
 “Loan Amendments” has the meaning set forth in the recitals. 

“Losses” means any and all losses, Claims, damages, liabilities, settlement costs and expenses,
including reasonable attorneys’ fees. 
 “Material Adverse Effect” means (i) a
material adverse effect on the results of operations, assets, business, prospects or financial condition of the Company and the Subsidiaries taken as a whole on a consolidated basis, or (ii) any impairment of the Company’s ability to
perform its obligations under any of the Transaction Documents; provided, however, that, none of the following alone shall be deemed, in and of itself, to constitute a Material Adverse Effect: (A) a change in the market price or
trading volume of the Common Stock; (B) changes in general economic conditions or changes affecting the industry in which the Company operates generally (as opposed to Company-specific changes) so long as such changes do not have a
disproportionate effect on the Company and its Subsidiaries taken as a whole; (C) changes in, or effects arising from or relating to, national or international political or social conditions generally or the occurrence or the escalation of any
military, cyber or terrorist attack upon the United States, (D) changes in, or effects arising from or relating to, the financial, banking or securities markets generally (including (1) any disruption of any of the foregoing markets,
(2) any change in currency exchange rates, and (3) any decline or rise in the price of any security, commodity, contract or index), and (E) changes in, or effects arising from or relating to, any changes (after the date hereof in) in
laws, rules, regulations orders. 
 “NASDAQ” means the NASDAQ Global Select Market, the NASDAQ Global
Market or the NASDAQ Capital Market, as applicable. 
 “Notice” has the meaning set forth in
Section 9.5. 
 “Person” means an individual, a limited liability company, a partnership,
a joint venture, a corporation, a trust, an unincorporated organization, a government or any department or agency thereof and any other legal entity. 

“Preferred Shares” has the meaning set forth in the recitals. 

“Preferred Stock” has the meaning set forth in the recitals. 

“Proceeding” means an action, claim, suit, investigation or proceeding (including a partial proceeding,
such as a deposition or other discovery activity), in any judicial, administrative, arbitral or regulatory forum, whether commenced or threatened in writing. 

“Prohibited Transaction” has the meaning set forth in Section 5.9. 

  
 6 

 “Property” means any interest in any kind of property or
asset, whether real, personal or mixed, or tangible or intangible. 
 “Purchase Price” has the meaning
set forth in Section 1.2(a). 
 “Registration Rights Agreement” has the meaning set forth in the recitals.

 “Regulation D” has the meaning set forth in the recitals. 

“Restricted Security” has the meaning set forth in Section 6.3. 

“Rule 144,” “Rule 144A,” “Rule 415,” and
“Rule 424” means Rule 144, Rule 144A, Rule 415 and Rule 424, respectively, promulgated by the SEC pursuant to the Securities Act, as such rules may be amended from time to time, or any similar rule or regulation hereafter
adopted by the SEC having substantially the same effect as such Rule. 
 “SEC” means the United States
Securities and Exchange Commission. 
 “SEC Reports” has the meaning set forth in Section 4.6(a). 

“Section 14 Filing” has the meaning set forth in Section 7.3. 

“Securities” has the meaning set forth in the recitals. 

“Securities Act” means the Securities Act of 1933, and the rules and regulations of the SEC promulgated
thereunder, as from time to time amended. 
 “Short Sales” has the meaning set forth in Section
5.9. 
 “Solomon Options” means 70,000 stock option grants to purchase shares of the Common Stock
under the EveryWare, Global, Inc. 2013 Omnibus Incentive Compensation Plan made to Samie Solomon in connection with his entry into an Employment Agreement with the Company dated as of June 9, 2014. 

“Stockholder Meeting” has the meaning set forth in Section 7.3. 

“Subsidiary” means any entity in which the Company, directly or indirectly, owns a majority of the
outstanding equity and/or control. 
 “Term Loan Amendment” has the meaning set forth in the recitals.

 “Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market (other
than the OTC Bulletin Board), (ii) if the Common Stock is not listed or quoted on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin
Board, or (iii) if the Common Stock is not listed or quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the Pink Sheets LLC (or any similar organization or agency succeeding to
its functions of reporting prices); provided, that, in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) above, then Trading Day shall mean a Business Day. 

  
 7 

 “Trading Market” means whichever of the New York Stock
Exchange, the NYSE MKT, NASDAQ or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 

“Transaction Documents” means, collectively, this Agreement, the schedules and exhibits attached hereto,
and any and all agreements, certificates, instruments and other documents of any Company Party required thereby or executed in connection hereto (including the Warrants, the Lender Warrant Agreement, the COD, the Loan Amendments and the Registration
Rights Agreement). 
 “Warrants” has the meaning set forth in the recitals. 

“Warrant Shares” has the meaning set forth in the recitals. 

(b) Rules of Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be
deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any
party. This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the
Transaction Documents. The words “hereof”, “herein” and “hereunder” and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement.
References to Articles, Sections, Exhibits and Schedules are to Articles, Sections, Exhibits and Schedules of this Agreement unless otherwise specified. All Exhibits and Schedules annexed hereto or referred to herein are hereby incorporated in and
made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Exhibit or Schedule but not otherwise defined therein, shall have the meaning set forth in this Agreement. Any singular term in this Agreement shall be
deemed to include the plural, and any plural term the singular. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “, but not
limited to,”, whether or not they are in fact followed by those words or words of like import. Except as the context may otherwise require, references to any agreement or contract are to that agreement or contract as amended or supplemented
from time to time in accordance with the terms hereof and thereof; provided, however, that with respect to any agreement or contract listed on any Schedules hereto, all such amendments or supplements must also be listed in the
appropriate Schedule. References to a statute shall be to such statute, as amended from time to time, and to the rules and regulations promulgated thereunder; provided, however, that for the purposes of the representations and
warranties set forth herein, with respect to any violation or alleged violation of any statute, the reference to such statute means such statute as in effect at the time of such violation or alleged violation. References to any Person include the
successors and permitted assigns of that Person. References from or through any date mean, unless otherwise specified, from and including or through and including, respectively. 

  
 8 

 2. Preferred Shares and Warrants; Purchase Price; Closing. 

2.1. At the Closing, on the terms and subject to the conditions of this Agreement, each Investor, severally and not jointly, will purchase
from the Company, and the Company will issue and sell to each Investor, such number of Preferred Shares and Warrants set forth on such Investor’s signature page to this Agreement. 

2.2. The purchase price in respect of all the Preferred Shares and Warrants shall be an aggregate of $20,000,000 (the “Purchase
Price”). 
 2.3. The purchase and delivery of the Preferred Shares and Warrants to be purchased by the Investors shall take
place at the offices of Proskauer Rose LLP, 11 Times Square, New York, NY 10036, at a closing (the “Closing”) on the Closing Date. 

2.4. At the Closing, the Company will deliver or cause to be delivered to each Investor: 

(a) one or more stock certificates free and clear of all restrictive and other legends (except as expressly provided in
Section 6.1) and evidencing the number of Preferred Shares set forth on such Investor’s signature page to this Agreement, registered in the name of such Investor; 

(b) one or more Warrants free and clear of all restrictive and other legends (except as expressly provided in Section 6.1),
issued in the name of such Investor, pursuant to which such Investor shall have the right to acquire such number of Warrant Shares set forth on such Investor’s signature page to this Agreement, registered in the name of such Investor; 

(c) a certificate of an officer of the Company, dated the Closing Date (the “Company Certificate”), in the form
attached hereto as Exhibit C; and 
 (d) a certificate of the Secretary of the Company, dated the Closing Date (the “Company
Secretary’s Certificate”), in the form attached hereto as Exhibit D. 
 2.5. At the Closing, each Investor shall deliver or
cause to be delivered to the Company: 
 (a) such Investor’s respective portion of the Purchase Price in respect of the Preferred
Shares and Warrants being purchased by such Investor at the Closing, as set forth on (or otherwise calculated in accordance with) such Investor’s signature page to this Agreement, in United States dollars and in immediately available funds, by
wire transfer to an account designated in writing to such Investor by the Company for such purpose at least one Business Day prior to such Closing; and 

(b) a certificate of an officer of such Investor, dated the Closing Date (the “Investor Certificate”), in the form
attached hereto as Exhibit E. 
 3. Additional Closing Deliverables. At or prior to the Closing: 

  
 9 

 3.1. Listing Approval. The Company will deliver to the Investors evidence that all the
Warrant Shares shall have been approved for listing on NASDAQ, subject only to official notice of issuance. 
 3.2. Loan
Amendments. The Company will deliver to the Investors copies of the Loan Amendments executed and delivered by the parties thereto. 

3.3. COD. The Company will deliver evidence to the Investors that the COD has been filed with the Secretary of State of the State of
Delaware and the COD has become effective. 
 3.4. Registration Rights Agreement. (a) The Company will deliver to the Investors
a copy of the Registration Rights Agreement executed and delivered by the Company and the other parties thereto (other than the Investors); and (b) the Investors will deliver to the Company a copy of the Registration Rights Agreement executed
and delivered by the Investors. 
 3.5. Fees and Expenses. The Company will pay to the Investors the Fees Due Upon Issuance. 

3.6. Financial Projections. The Company will deliver to the Investors financial projections of the Company and its consolidated
subsidiaries through December 31, 2016. 
 4. Representations and Warranties of the Company. Except as disclosed in the SEC
Reports (excluding (1) any risk factor or similar disclosures contained in any such SEC report under the heading “Risk Factors” or any similar heading, (2) any disclosure of risks or other matters included in any
“forward-looking statements” or any similar disclaimer, and (3) other statements that are cautionary, predictive or forward-looking in nature), the Company hereby represents and warrants as of the date hereof and as of the Closing
Date to the Investors as follows: 
 4.1. Organization and Qualification. Each Company Party is an entity duly organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or formation, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Each Company
Party is not in violation of any of the provisions of its certificate or articles of incorporation, by-laws or other organizational or charter documents (the “Charter Documents”). Each Company Party is duly qualified to do
business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or
in good standing, as the case may be, would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 

4.2. Authorization; Enforcement. Each Company Party has the requisite power and authority to enter into and to consummate the
transactions contemplated by each of the Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each of the Transaction Documents to which it is a party by each
Company Party and the consummation by it of the transactions contemplated 

  
 10 

 
hereby and thereby have been duly authorized by all necessary action on the part of such Company Party and no further consent or action is required by such Company Party, its board of directors
(or similar governing body), members, managers, partners, stockholders or other equityholders (as applicable). Each of the Transaction Documents to which it is a party has been (or upon delivery will be) duly executed by each Company Party and
constitutes, or when delivered in accordance with the terms hereof will constitute, the valid and binding obligation of such Company Party enforceable against such Company Party in accordance with its terms, except (a) as limited by general
equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (b) as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable remedies, and (c) insofar as indemnification and contribution provisions may be limited by applicable law. 

4.3. No Conflicts. The execution, delivery and performance of the Transaction Documents to which each Company Party is a party and the
consummation by such Company Party of the transactions contemplated hereby and thereby do not, and will not, (a) conflict with or violate any provision of the Charter Documents, (b) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice or lapse of time or both) of, or result in the creation of any lien,
security interest, charge or encumbrance upon any of the properties or assets of such Company Party under the terms or conditions of, any agreement, credit facility, debt or other instrument (evidencing such Company Party’s debt or otherwise)
to which such Company Party is a party or by which any property or asset of such Company Party is bound, or affected, except to the extent that such conflict, default, termination, amendment, acceleration or cancellation right would not reasonably
be expected to have a Material Adverse Effect, or (c) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which such Company Party is subject
(including, assuming the accuracy of the representations and warranties of the Investors set forth in Section 5, federal and state securities laws and regulations and the rules and regulations of any self regulatory organization to which
such Company Party or its securities are subject, including all applicable Trading Markets), or by which any property or asset of such Company Party is bound or affected. 

4.4. Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens and will not be subject to preemptive or similar rights of stockholders. The Company shall authorize and reserve for issuance such shares of
Common Stock such that there shall be reserved from the Company’s capital stock not less than the maximum number of Warrant Shares issuable on exercise of the Warrants. No vote of any class or series of capital stock of or any equity interests
in or other securities of the Company is necessary to approve the issuance of the Preferred Stock and the Warrants. No vote of any class or series of capital stock of or any equity interests in or other securities of the Company is necessary to
approve the issuance of the Warrant Shares except for the stockholder approval the Company will seek to obtain at the Stockholder Meeting. 

  
 11 

 4.5. Capitalization. The authorized, issued and outstanding capital stock of the Company
as of April 14, 2014 is as set forth in the Company’s Annual Report on Form 10-Q for the quarter ended March 31, 2014 and filed with the SEC on May 15, 2014. As of the date hereof, 22,120,023 shares of Common Stock are issued and
outstanding. Other than in the categories, and in the aggregate amount of Common Shares issuable in respect of each such category, as set forth on Schedule 4.5 and, other than the Warrants and Lender Warrants, as of the date hereof, the
Company does not have outstanding as of the date hereof any options, script rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible or exercisable into or exchangeable
for, and the Company has not entered into any agreement giving any Person any right to subscribe for or acquire, any Securities, Common Stock or Convertible Securities, or securities, rights or obligations convertible or exercisable into or
exchangeable for any Securities, Common Stock or Convertible Securities. The issuance and sale of any Securities will not obligate the Company to issue Securities or Common Stock or other securities to any Person (other than the Investors) and will
not result in a right of any holder of securities to adjust the exercise, conversion, exchange or reset price under any securities issued by the Company (or in any agreement providing rights to security holders). To the knowledge of the Company,
except as disclosed in the SEC Reports filed prior to the date hereof and any Schedules 13D or 13G filed with the SEC pursuant to Rule 13d-1 of the Exchange Act, no Person or group of related Persons beneficially owns (as determined pursuant to Rule
13d-3 under the Exchange Act), or has the right to acquire, by agreement with or by obligation binding upon the Company, beneficial ownership in excess of 5% of the outstanding Common Stock, other than the Warrants and the Lender Warrants. As of the
date hereof, the Warrant Shares represent 15% of the total number of shares of Common Stock outstanding (assuming the exercise of the Solomon Options, all the Warrants and all the Lender Warrants). 

4.6. SEC Reports; Financial Statements. 

(a) Other than the Company’s Current Report on Form 8-K dated as of February 28, 2104 and filed with the SEC on April 21,
2014, the Company has filed all reports required to be filed by it with the SEC under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, since May 21, 2013, on a timely basis or has received a valid extension of such
time of filing and has filed any such reports prior to the expiration of any such extension. Such reports filed by the Company with the SEC under the Exchange Act since May 21, 2013 and prior to the date hereof, including pursuant to
Section 13(a) or 15(d) thereof, together with any materials filed or furnished by the Company under the Exchange Act, whether or not any such reports were required, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the “SEC Reports.” 
 (b) As of their respective dates (or, if
amended or superseded by a filing prior to the date hereof, then on the date of such filing), the SEC Reports filed by the Company complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and
regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed (or, if amended or superseded by a filing prior to the date hereof, then on the date of such filing) by the Company, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to make the 

  
 12 

 
statements therein, in the light of the circumstances under which they were made, not misleading. All material agreements to which the Company is a party or to which the property or assets of the
Company are subject are included as part of or identified in the SEC Reports, to the extent such agreements are required to be included or identified therein pursuant to the rules and regulations of the SEC. 

(c) The financial statements of the Company included in the SEC Reports comply in all material respects with the rules and regulations of the
SEC with respect thereto as in effect at the time of filing (or, if amended or superseded by a filing prior to the Closing Date, then on the date of such filing). Such financial statements have been prepared in accordance with United States
generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements, the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP or may be condensed or summary statements, and fairly present the consolidated financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year end audit adjustments. 

4.7. Solvency. On the Closing Date immediately after giving effect to the transactions contemplated hereby to occur at or prior to the
Closing, including the Loan Amendments, the Company will not be, Insolvent (as defined below). For purposes of this Section 4.7, “Insolvent” means (i) the present fair saleable value of the Company’s
assets is less than the amount required to pay the Company’s total Indebtedness, (ii) the Company is unable to pay its debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured,
or (iii) the Company has unreasonably small capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted immediately following the Closing. 

4.8. No General Solicitation; Placement Agent’s Fees. Neither the Company nor any of its officers or directors, nor, to the
Company’s knowledge, any of its Affiliates or any Person acting on its or his, her or their behalf, has engaged in any form of general solicitation or general advertising (as defined in Regulation D) in connection with the offer or sale of the
Securities; provided, however, that no representation is made pursuant to this sentence with respect to the Investors or any of their Affiliates (other than the Company and its Subsidiaries). The Company shall be responsible for the
payment of any placement agent’s fees, financial advisory fees, or brokers’ commission (other than for persons engaged by any Investors or their respective investment advisors) relating to or arising out of the issuance of the Securities
pursuant to this Agreement. The Company shall pay, and hold the Investors harmless against, any liability, loss or expense (including reasonable attorney’s fees and out-of-pocket expenses) arising in connection with any such claim for fees
arising out of the issuance of the Securities pursuant to this Agreement. The Company has not engaged any placement agent or other agent in connection with the offer, sale or issuance of the Securities. 

4.9. Private Placement; Investment Company. Neither the Company nor any of its Affiliates nor any Person acting on the Company’s
behalf has, directly or indirectly, at any time within the past six months, made any offer or sale of any security or solicitation of any offer to buy any security under circumstances that would (a) eliminate the availability of the

  
 13 

 
exemption from registration under Regulation D in connection with the offer and sale by the Company of the Securities as contemplated hereby, or (b) cause the offering of the Securities
pursuant to the Transaction Documents to be integrated with prior offerings by the Company for purposes of any applicable law, regulation or stockholder approval provisions, including under the rules and regulations of any Trading Market. Assuming
the accuracy of the representations and warranties of the Investors set forth in Section 5, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Investors as contemplated
hereby. The sale and issuance of the Securities hereunder does not contravene the rules and regulations of any Trading Market on which the Common Stock is listed or quoted. The Company is not required to be registered as, and is not an Affiliate of,
an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 
 4.10. Bad Actor. No
“bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act, except for an event to which Rule 506(d)(2)(ii-iv) or (d)(3) is applicable (a “Disqualification Event”) is applicable
to the Company or, to the Company’s knowledge, any Company Covered Person. 
 4.11. Consents. Except as set forth on Schedule
4.11, the Company is not required to obtain any consent, authorization or order of, or make any filing or registration with, any court, governmental agency or any regulatory or self-regulatory agency or any other Person in order for it to
execute, deliver or perform any of its obligations under or contemplated by the Transaction Documents, in each case in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations set forth in items 1
and 2 of Schedule 4.11 have been obtained or effected on or prior to the Closing Date. 
 4.12. Compliance. Except as would
not, individually or in the aggregate, reasonably be expected to have or result in a Material Adverse Effect, (a) the Company is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or
lapse of time or both, would result in a default by the Company under), nor has the Company received written notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement
or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (b) the Company is not in violation of any order of any court, arbitrator or governmental body, or
(c) the Company is not and has not been in violation of any statute, rule or regulation of any governmental authority. 
 4.13.
Internal Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (a) transactions are executed in accordance with management’s general or specific
authorizations, (b) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability, (c) access to assets is permitted
only in accordance with management’s general or specific authorization, and (d) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any
differences. During the 12 months prior to the date hereof, neither the Company nor any of its Subsidiaries have received any notice or correspondence from any accountant relating to any potential material weakness in any part of the system of
internal accounting controls of the Company or any of its Subsidiaries. 

  
 14 

 4.14. Sarbanes-Oxley Act. The Company is in compliance in all material respects with any
applicable requirements of the Sarbanes-Oxley Act of 2002 and any applicable rules and regulations promulgated by the SEC thereunder. 

4.15. Reliance by the Investors. The Company acknowledges that the Investors will rely upon the truth and accuracy of, and the
Company’s compliance with, the representations, warranties, covenants, agreements, acknowledgements and understandings of the Company set forth herein. 

4.16. Subsidiary Rights. Other than pursuant the credit agreements of the Company and its Subsidiaries, neither the Company nor any of
its Subsidiaries is party to any agreement that would reasonably be expected to materially impair the right to vote, and (subject to limitations imposed by applicable law) to receive dividends and distributions on, all capital securities of its
Subsidiaries as owned by the Company or such Subsidiary. 
 4.17. Proceedings Related to Transactions. No action, suit or proceeding
by or before any court or any governmental body or authority, against the Company or any Subsidiary or pertaining to the transactions contemplated by the Securities Purchase Agreement or their consummation, has been instituted on or before the
Closing Date, which action, suit or proceeding would, if determined adversely, have a Material Adverse Effect. 
 5. Representations and
Warranties of the Investors. Each Investor, severally and not jointly, hereby represents and warrants to the Company as follows: 
 5.1.
Organization; Authority. Such Investor is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite power and authority to enter into and to consummate the
transactions contemplated by each of the Transaction Documents to which it is party and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each Transaction Document to which such Investor is a party and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of such Investor and no further consent or action is required by such Investor, its board of directors (or
similar governing body), members, managers, partners, stockholders or other equityholders (as applicable). Each of the Transaction Documents to which it is a party has been (or upon delivery will be) duly executed by such Investor and constitutes,
or when delivered in accordance with the terms hereof, will constitute, the valid and binding obligation of such Investor, enforceable against it in accordance with its terms, except (a) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (b) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies, and (c) insofar as indemnification and contribution provisions may be limited by applicable law. 
 5.2.
No Public Sale or Distribution. Such Investor is acquiring the Securities in the ordinary course of business for its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except
pursuant to sales registered under the Securities Act or under an exemption from such registration and in compliance with 

  
 15 

 
applicable federal and state securities laws, and such Investor does not have a present arrangement to effect any distribution of Securities to or through any Person; provided,
however, that by making the representations herein, such Investor does not agree to hold any of Securities for any minimum or other specific term and reserves the right to dispose of Securities at any time in accordance with or pursuant to a
registration statement or an exemption under the Securities Act. 
 5.3. Investor Status. At the time such Investor was offered the
Securities, it was, and at the date hereof it is, a “qualified institutional buyer”, as defined in Rule 144A(a) under the Securities Act. Such Investor is not a registered broker-dealer registered under Section 15(a) of the Exchange
Act, or a member of the Financial Regulatory Authority, Inc. (“FINRA”) or an entity engaged in the business of being a broker-dealer. Except as otherwise set forth on Schedule 5.3 hereto, such Investor is not
affiliated with any broker-dealer registered under Section 15(a) of the Exchange Act, or a member of FINRA or an entity engaged in the business of being a broker-dealer. 

5.4. General Solicitation. Such Investor is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media, broadcast over television or radio, disseminated over the Internet or presented at any seminar or any other general solicitation or general advertisement.

 5.5. Experience of Each Investor. Such Investor, either alone or together with its representatives has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Investor
understands that it must bear the economic risk of this investment in the Securities indefinitely, and is able to bear such risk and is able to afford a complete loss of such investment. 

5.6. Access to Information. Such Investor acknowledges that it has been afforded: (a) the opportunity to ask such questions as it
has deemed necessary of, and to receive answers from, representatives of the Company concerning the Company’s business, management and financial affairs and terms and conditions of the offering of the Securities and the merits and risks of
investing in the Securities; (b) access to information (including material nonpublic information) about the Company and its Subsidiaries and their respective financial condition, results of operations, business, properties, management and
prospects sufficient to enable it to evaluate its investment; and (c) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed
investment decision with respect to the investment. Such Investor has evaluated the risks of investing in the Securities, understands there are substantial risks of loss incidental to the investment and has determined that it is a suitable
investment for such Investor. 
 5.7. No Governmental Review. Such Investor understands that no United States federal or state
agency or any other government or governmental agency has passed upon or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed
the merits of the offering of the Securities. 

  
 16 

 5.8. No Conflicts. The execution, delivery and performance by such Investor of each
Transaction Document to which it is a party and the consummation by such Investor of the transactions contemplated hereby and thereby will not (a) conflict with or violate any provision of the organizational documents of such Investor,
(b) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice or
lapse of time or both) of, any agreement, indenture or instrument to which such Investor is a party or by which any property or asset of such Investor is bound or affected, or (c) result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental authority to which such Investor is subject (including federal and state securities laws) or by which any property or asset of such Investor is bound or affected, except
in the case of clauses (b) and (c) above, for such that are not material to the transactions contemplated by this Agreement and do not otherwise affect the ability of such Investor to consummate the transactions contemplated hereby. 

5.9. Prohibited Transactions; Confidentiality. Such Investor has not, directly or indirectly, and no Person acting on behalf of or
pursuant to any understanding with such Investor has, engaged in any purchases or sales in the securities, including derivatives, of the Company (including any Short Sales (a “Prohibited Transaction”) involving any of the
Company’s securities) since the time that such Investor was first contacted by the Company, the Agent or any other Person regarding an investment in the Company. Such Investor covenants that neither it nor any Person acting on its behalf or
pursuant to any understanding with such Investor will engage, directly or indirectly, in any Prohibited Transactions in the securities of the Company (including Short Sales) prior to the time the transactions contemplated by this Agreement are
publicly disclosed. “Short Sales” means all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act. 

5.10. Restricted Securities. Such Investor understands that the Securities are characterized as “restricted securities” under
the U.S. federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the
Securities Act only in certain limited circumstances. 
 5.11. Legends. It is understood that, except as provided in
Section 6.1, certificates evidencing the Securities will bear any legend as required by the Blue Sky laws of any state and a restrictive legend in substantially the form set forth in Section 6.1. 

5.12. Residency. Such Investor is a resident of that jurisdiction specified below its address set forth on such Investor’s
signature page to this Agreement. 
 5.13. Bad Actor. To the extent that any Investor is, prior to the Closing, a beneficial owner
(as determined pursuant to Rule 13d-3 under the Exchange Act) of 20% or more of the Company’s outstanding voting equity securities, neither such Investor nor, to the knowledge of such Investor, any Affiliate of such Investor who is also the
beneficial owner (as determined pursuant to Rule 13d-3 under the Exchange Act) of 20% or more of the Company’s outstanding voting equity securities is subject to any Disqualifying Event that would cause the exemption provided for in Rule
506 under the Securities Act to be unavailable with respect to the issuance of the Warrants and the Preferred Shares. 

  
 17 

 5.14. No Additional Representations or Warranties. Except for the representations and
warranties contained in the Transaction Documents, the Investors acknowledge that the Company makes no other express or implied representation or warranty with respect to the Company or any of its Subsidiaries in connection with any of the
Transaction Documents. 
 6. Restrictions on Transfer 

6.1. Securities Restrictive Legends. 

(a) Certificates representing the Securities issued will bear any legend as required by the “blue sky” laws of any state and a
restrictive legend in substantially the following form until such time as they are permitted to be removed under this Section 6 or applicable law: 

THIS SECURITY[, AS WELL AS THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY,] HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS SECURITY[, AS WELL AS THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY,] MAY NOT BE OFFERED FOR SALE, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED (I) IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, (II) IN THE ABSENCE OF AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS, AS EVIDENCED (IF REQUIRED BY THE COMPANY) BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT, OR (III) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE
SECURITIES ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER REPRESENTATION LETTER AND A BROKER REPRESENTATION LETTER, IN EITHER CASE AS MAY BE APPLICABLE) THAT THE SECURITIES MAY BE SOLD
PURSUANT TO SUCH RULE). NO REPRESENTATION IS MADE BY THE COMPANY AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT FOR RESALES OF THIS SECURITY[, OR THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY] 

(b) The Company shall maintain a copy of this Agreement and any amendments thereto on file in its principal offices, and will make such copy
available during normal business hours for inspection to any party thereto or will provide such copy to each Investor or any transferee upon its or their request. 

(c) Whenever the legend imposed by this Section 6.1 may be removed, as provided in Section 6.2, the respective
holders of Securities for which such legend requirements have terminated shall be entitled to receive from the Company, at the Company’s expense, certificates representing Securities without such legend as provided in Section 6.2.

  
 18 

 6.2. Notice of Transfer; Opinions of Counsel. Each holder of Securities bearing the
restrictive legend set forth in Section 6.1 (a “Restricted Security”), with respect to any transfer of such Restricted Security, will give to the Company (a) notice describing the transferee and the
circumstances, if any, necessary to establish the availability of an exemption from the registration or qualification requirements of the Securities Act or any applicable state securities law, and (b) upon reasonable request by the Company to
such transferring holder at the expense of such holder, an opinion of counsel (which may be in-house counsel or outside counsel to an Investor or its investment adviser) in form and substance reasonably satisfactory to the Company to the effect that
the proposed transfer of such Restricted Security may be effected without registration or qualification of such Restricted Security under the Securities Act or any applicable state securities law. If for any reason the Company (after having been
furnished with the opinion requested to be furnished pursuant to this Section 6.2), shall fail to notify such holder within ten Business Days after such holder shall have delivered such opinion to the Company that, in its counsel’s
opinion, the transfer may not be legally effective (the “Illegal Transfer Notice”), such holder thereupon will be entitled to transfer the Restricted Security as proposed. If (i) the holder of the Restricted Security
delivers to the Company an opinion of counsel (which may be in-house counsel or outside counsel to an Investor or its investment adviser) which is in form and substance reasonably satisfactory to the Company that subsequent transfers of such
Restricted Security will not require registration under the Securities Act or any applicable state securities law, and (ii) the Company does not provide the holders with an Illegal Transfer Notice as set forth above, the Company promptly
following such contemplated transfer (and in any event within three Business Days), at the expense of such holder, will deliver new certificates for such Restricted Security which do not bear the Securities Act legend set forth in
Section 6.1(a). The restrictions imposed by this Section 6 upon the transferability of any particular Restricted Security shall cease and terminate when such Restricted Security has been sold pursuant to an effective
registration statement under the Securities Act or transferred pursuant to Rule 144 promulgated under the Securities Act. The holder of any Restricted Security, as to which the restrictions imposed by this Section 6 shall have
terminated, shall be entitled to receive from the Company, at the expense of the Company, a new security of the same type but not bearing the restrictive Securities Act legend set forth in Section 6.1 and not containing any other
reference to the restrictions imposed by this Section 6. Notwithstanding any of the foregoing, no opinion of counsel will be required to be rendered pursuant to this Section 6.2 with respect to the transfer of any securities
on which the restrictive legend has been removed in accordance with this Section 6.2. As used in this Section 6.2, the term “transfer” encompasses any sale, transfer or other disposition of any securities
referred to herein. 
 7. Covenants and Other Agreements. 

7.1. Shares Issuable Upon Exercise. At any time that the Warrants are outstanding, the Company shall cause to be maintained all
authorizations required for the issuance of a number of shares of Common Stock which the Company may be liable to issue upon exercise of the Warrants from time to time remaining outstanding, in accordance with the terms and conditions of the
Warrants. All shares of Common Stock delivered upon exercise of 

  
 19 

 
the Warrants shall be newly issued shares or shares held in treasury by the Company, shall have been duly authorized and validly issued and shall be fully paid and non-assessable and free of any
Lien and shall not be subject to any pre emptive rights or similar rights and shall rank pari passu in all respects with other existing Common Stock. 

7.2. Issuance and Voting Limits. Unless and until the Company obtains any stockholder approval required by NASDAQ Listing Rule 5635 to
permit full exercisability of the Warrants, the number of shares of Common Stock for which the Warrants will be exercisable will be limited to the number of shares of Common Stock that, when taken to together with all shares of Common Stock issued
or issuable upon exercise of the Lender Warrants, would be equal to 19.9% of the outstanding shares of Common Stock as of the date of this Agreement. 

7.3. The Stockholder Meeting. Promptly and within 20 days following the date hereof, the Company prepare and file with the SEC a proxy
statement, as applicable, meeting the requirements of Section 14 of the Exchange Act (the “Section 14 Filing”) soliciting each such stockholders’ affirmative vote at the Stockholder Meeting for approval of the
Company’s issuance of the Warrant Shares and the shares issuable upon exercise of the Lender Warrants. The Company promptly will respond to any comments to the Section 14 Filing from the SEC. The Company will hold a special meeting of
stockholders of the Company to approve the issuance of the Warrant Shares and the shares issuable upon exercise of the Lender Warrants (the “Stockholder Meeting”) promptly following completion of review of the Section 14
Filing by the SEC (or confirmation by the SEC that it will not review the Section 14 Filing). The Board of Directors will recommend that all stockholders entitled to vote at the Stockholder Meeting approve all matters on which such stockholders
are entitled to vote. The Stockholder Meeting will be conducted, the Section 14 Filing will be prepared and all required mailings to stockholders will be made, in accordance with SEC rules and regulations, other applicable Federal and state
law, the rules and regulations of the NASDAQ, the Charter and the By-laws. Each of the Investors hereby irrevocably and unconditionally agrees that it shall (a) appear at the Stockholder Meeting or otherwise cause all the shares of Common Stock
held by it as of the record date of the Stockholder Meeting to be counted as present thereat for purposes of calculating a quorum, and (b) vote (or cause to be voted) such shares in favor of approving the Company’s issuance of the Warrant
Shares and the shares of Common Stock issuable upon exercise of the Lender Warrants and all other applicable transactions contemplated in this Agreement. 

7.4. No Commitment for Additional Financing. The Company acknowledges and agrees that none of the Investors has made any
representation, warranty, undertaking, commitment, covenant or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Preferred Shares as set forth herein and subject to
the conditions set forth herein. In addition, the Company acknowledges and agrees that (a) no statements, whether written or oral, made by any of the Investors or its representatives on or after the date of this Agreement shall create an
obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (b) the Company shall not rely on any such statement by any of the Investors or its representatives, and (c) an obligation,
commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, 

  
 20 

 
signed by such Investor and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or
agreement. Each Investor shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in
obtaining any financing, investment or other assistance. 
 7.5. Form D; Blue Sky laws. The Company agrees to file a Form D with
respect to the Securities as required under Regulation D and to provide a copy thereof to each Investor promptly after such filing. The Company shall, on or before the Closing Date, take such action as the Company shall reasonably determine is
necessary in order to obtain an exemption for or to qualify the Securities for sale to the Investors at the Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain
an exemption from such qualification), and shall provide evidence of any such action so taken to the Investors on or prior to the Closing Date. The Company shall make all filings and reports relating to the offer and sale of the Securities required
under applicable securities or “Blue Sky” laws of the states of the United States following the Closing Date. 
 7.6. Reporting
Status. Without prior written consent of the Investors, until the date on which (a) the Investors shall have sold all the Warrant Shares, and (b) none of the Preferred Shares or Warrants is outstanding, the Company shall file all
reports required to be filed with the SEC pursuant to the Exchange Act, and the Company shall not terminate its status as an issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder
would otherwise permit such termination. 
 7.7. Register of Preferred Shares and Warrants. The Company shall maintain at its
principal executive offices (or such other office or agency of the Company as it may designate by notice to each holder of Securities), a register for the Preferred Shares and the Warrants in which the Company shall record the name and address of
the Person in whose name the Preferred Shares and the Warrants have been issued (including the name and address of each transferee) and the number of Preferred Shares and Warrants held by such Person. The Company shall keep the register open and
available at all times during business hours for inspection of any Investor or its legal representatives. 
 7.8. No Amendment to Lender
Warrant Agreement. The Company shall not consent to, or enter into, any amendment of or supplement to the Lender Warrant Agreement or any of the Lender Warrants without the prior written consent of the Investors, other than any amendment of the
Lender Warrant Agreement not requiring the written consent of the majority of the registered holders of warrants thereunder in accordance with the first sentence of Section 8.8 of the Lender Warrant Agreement. 

7.9. Listing of Warrant Shares. In the time and manner required by the Trading Market, the Company shall prepare and file with such
Trading Market additional shares listing application covering all the Warrant Shares and shall use its best efforts to take all steps necessary to cause all of the Warrant Shares to be approved for listing on the Trading Market as promptly as
possible thereafter. 

  
 21 

 7.10. Certain Transactions. The Company will not merge or consolidate into, or sell,
transfer or lease all or substantially all of its property or assets to, any other party unless the successor, transferee or lessee party, as the case may be (if not the Company), assumes (expressly or by operation of law) the due and punctual
performance and observance of each and every covenant and condition of this Agreement to be performed and observed by the Company. 
 7.11.
Corporate Opportunities. The Company and the Investors acknowledge the provisions of Article IX of Charter, which provisions hereby are incorporated by reference in this Section 7.11. 

8. Termination. This Agreement may be terminated by the Company or any Investor, by written notice to the other parties, if the Closing
has not been consummated by the third Trading Day following the date of this Agreement; provided, however, that no termination may be made under this Section 8 if the failure to consummate the Closing by such date shall be
caused by the breach or action or inaction of the party seeking to terminate this Agreement pursuant to this Section 8; provided further, however, that no such termination will affect the right of any party to sue for any
breach by the other party (or parties). 
 9. Miscellaneous. 

9.1. Public Communications. No press release or public announcement related to this Agreement or the transactions contemplated hereby
shall be issued or made without the joint approval of the Investors and the Company, unless required by law, in which case the Investors and the Company, as applicable, shall have the right to review and comment on such press release or announcement
prior to such issuance or making. 
 9.2. Fees and Expenses. The Company shall pay all fees, stamp taxes and other taxes and duties
levied in connection with the sale and issuance of the Securities (including the issuance of the Warrant Shares). The Company shall reimburse the Investors for the reasonable fees and expenses Investor incurs in connection with the transactions
contemplated hereby, including the investment in the Securities, the Stockholder Meeting, and the exercise of any registration rights under the Registration Rights Agreement. The amount to be reimbursed in connection with the investment in the
Preferred Shares and Warrants is the amount of the Fees Due Upon Issuance. The Company and the Investors also acknowledge hereby that $1,2000,000 in Liquidation Value of the Preferred Shares is a fee for investing in the Preferred Shares, payable in
additional Preferred Shares at Closing. 
 9.3. Indemnification. 

(a) The Company Parties shall, notwithstanding any termination of this Agreement, indemnify and hold harmless, jointly and severally, each
Investor, each Investor’s managers, members, stockholders, partners, other equity owners, officers, directors, successors, assigns, agents, attorneys and employees and each Person who controls such Investor (within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act), to the fullest extent permitted by applicable law, from and against any and all Losses, as incurred, arising out of or based on (a) any misrepresentation or breach
of any representation or warranty made by a Company Party in the Transaction Documents or any other certificate, instrument or 

  
 22 

 
document contemplated hereby or thereby, (b) any breach of any agreement or obligation by a Company Party of any Transaction Document, or (c) any Proceeding in connection with, arising
out of, or related to, any of the transactions contemplated by any of the Transaction Documents (including in connection with, arising out of, or related to, any of the matters to be voted on or approved at the Stockholder Meeting). 

(b) Each Investor shall, notwithstanding any termination of this Agreement, indemnify and hold harmless, severally and not jointly, the
Company, the Company’s managers, members, stockholders, partners, other equity owners, officers, directors, successors, assigns, agents, attorneys and employees and each Person who controls the Company (within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act), to the fullest extent permitted by applicable law, from and against any and all Losses, as incurred, arising out of or based on (a) any misrepresentation or breach of any
representation or warranty made by such Investor in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, or (b) any breach of any agreement or obligation by such Investor of any Transaction
Document. 
 9.4. Releases. 

(a) As of the Closing Date, the Company hereby fully, finally, irrevocably and indefeasibly releases, acquits and forever discharges the
Investor Released Parties from any and all Investor Released Claims of the Company against each such Investor Released Party. The Company (i) knowingly grants the release contemplated by this Section 9.4(a), notwithstanding that the
Company may hereafter discover facts in addition to, or different from, those which the Company now knows or believes to be true, without regard to the subsequent discovery or existence of such different or additional facts, and even if the Investor
Released Claims are not known or suspected to exist, and (ii) expressly waives (A) any assertion that the release contemplated by this Section 9.4(a) does not extend to Claims arising from conduct that occurred prior to the
Closing and relating in any manner to the Investor Released Claims that the Company did not know or suspect to exist in its favor as of the Closing, which if known by it, would have materially affected the release contemplated by this
Section 9.4(a), and (B) any and all rights that the Company may have under any applicable law that would limit the effect of the release contemplated by this Section 9.4(a). The Company will not commence, aid, or
participate in (except to the extent required by law or by order or legal process issued by a court or governmental agency of competent jurisdiction) any Proceeding to the extent in connection with, arising out of, or related to any of the Investor
Released Claims. 
 (b) As of the Closing Date, each Investor hereby fully, finally, irrevocably and indefeasibly releases, acquits and
forever discharges the Company Released Parties from any and all Company Released Claims. Each Investor (i) knowingly grants the release contemplated by this Section 9.4(b), notwithstanding that such Investor may hereafter discover
facts in addition to, or different from, those which such Investor now knows or believes to be true, without regard to the subsequent discovery or existence of such different or additional facts, and even if the Company Released Claims are not known
or suspected to exist, and (ii) expressly waives (A) any assertion that the release contemplated by this Section 9.4(b) does not extend to Claims arising from conduct that occurred prior to the Closing and relating in any
manner to the Company Released Claims that such Investor did not know or suspect to exist in 

  
 23 

 
its favor as of the Closing, which if known by it, would have materially affected the release contemplated by this Section 9.4(b), and (B) any and all rights that such Investor
may have under any applicable law that would limit the effect of the release contemplated by this Section 9.4(b). Each Investor agrees that it shall not commence, aid, or participate in (except to the extent required by law or by order
or legal process issued by a court or governmental agency of competent jurisdiction) any Proceeding to the extent in connection with, arising out of, or related to any of the Company Released Claims. 

9.5. Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire agreement and
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits
and schedules. At or after the Closing, and without further consideration, the Company and each Investor will execute and deliver such further documents as may be reasonably requested in order to give effect to the transactions contemplated by the
Transaction Documents. 
 9.6. Notices. All notices, consents, approvals, waivers or other communications (each, a
“Notice”) required or permitted hereunder, except as herein otherwise specifically provided, shall be in writing and shall be: (i) delivered personally or by commercial messenger; (ii) sent via a recognized
overnight courier service; (iii) sent by registered or certified mail, postage pre-paid and return receipt requested; or (iv) sent by facsimile transmission, provided confirmation of receipt is received by sender and the original Notice is
sent or delivered contemporaneously by an additional method provided in this Section 9.6; in each case so long as such Notice is addressed to the intended recipient thereof as set forth below: 

If to the Company: 

EveryWare Global, Inc. 

519 North Pierce Avenue 

Lancaster, OH 43130 

Attention: Legal Counsel 

Facsimile: (740) 681-6455 

with a copy (which shall not constitute notice) to: 

Kirkland & Ellis LLP 

300 N. LaSalle 

Chicago, IL 60614 

Attention:   Richard W. Porter, P.C. 

                   Carol Anne Huff

 Facsimile:  (312) 862-2200 

If to any Investor: 

At its address on the signature page hereto. 

  
 24 

 with copies (which shall not constitute notice) to: 

Proskauer Rose LLP 

11 Times Square 

New York, NY 10036 

Attention: James P. Gerkis 

Facsimile: (212) 969-2900 

Proskauer Rose LLP 

Three First National Plaza 

70 West Madison, Suite 3800 

Chicago, IL 60602 

Attention: Mark K. Thomas 

Facsimile: (312) 962-3551 

Any party may change its address specified above by giving each party Notice of such change in accordance with this Section 9.6. Any Notice shall
be deemed given upon actual receipt (or refusal of receipt). 
 9.7. Amendments; Waivers. No provision of this Agreement may be
waived or amended except in a written instrument signed, in the case of an amendment, by the Company and each of the Investors or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default
with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. 
 9.8.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the
prior written consent of each Investor. Any Investor may assign its rights under this Agreement to any Person to whom such Investor assigns or transfers any Securities, provided (i) such transferor agrees in writing with the transferee or
assignee to assign such rights, and a copy of such agreement is furnished to the Company after such assignment, (ii) the Company is furnished with written notice of the name and address of such transferee or assignee, and (iii) such
transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions hereof that apply to an “Investor”. 

9.9. No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and
permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except that (a) each party indemnified pursuant to Section 9.2 is an intended third-party beneficiary of
Section 9.2 and (in each case) may enforce the provisions of Section 9.2 applicable to them directly against the parties with obligations thereunder, and (b) each Company Released Party and Investor Released Party is an
intended third-party beneficiary of Section 9.4 and (in each case) may enforce the provisions of Section 9.4 applicable to them. 

  
 25 

 9.10. Governing Law; Venue; Waiver of Jury Trial. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. THE COMPANY AND EACH OF THE INVESTORS HEREBY IRREVOCABLY SUBMIT TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN
FOR THE ADJUDICATION OF ANY DISPUTE BROUGHT BY THE COMPANY OR ANY INVESTOR HEREUNDER, IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION
DOCUMENTS), AND HEREBY IRREVOCABLY WAIVE, AND AGREE NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE COMPANY OR ANY INVESTOR, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, OR THAT SUCH SUIT, ACTION
OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY
(WITH EVIDENCE OF DELIVERY) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE
DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY, PARENT AND EACH OF THE INVESTORS HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY. 

9.11. Survival. The representations and warranties contained herein shall survive the Closing for a period of one year following the
Closing Date. The covenants and agreements contained herein shall survive the Closing. 
 9.12. Execution. This Agreement may be
executed with counterpart signature pages or in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterpart signature pages or counterparts have been signed by
each party and delivered to the other party, it being understood that both parties need not sign the same counterpart signature page or counterpart. If any signature is delivered by facsimile transmission or email attachment, such signature shall
create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or email-attached signature page were an original thereof. 

9.13. Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and
upon so agreeing, shall incorporate such substitute provision in this Agreement. 
 9.14. Replacement of Stock Certificates. If any
certificate or instrument evidencing any of the Securities is mutilated, lost, stolen or destroyed, the Company shall issue 

  
 26 

 
or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate or note affidavit of that fact and an agreement to indemnify and hold harmless the Company for any
losses in connection therewith. The applicants for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement certificate or note. 

9.15. Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each Investor and the Company will be entitled to specific performance under the Transaction Documents without the posting of any bond or other security. The parties agree that monetary damages may not be adequate compensation for any loss incurred
by reason of any breach of obligations described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action for a temporary restraining order) the
defense that a remedy at law would be adequate. 
 9.16. Payment Set Aside. To the extent that the Company makes a payment or
payments to any Investor hereunder or any Investor enforces or exercises its rights hereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent
or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company by a trustee, receiver or any other Person under any law (including any bankruptcy law, state or federal law, common
law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such
enforcement or setoff had not occurred and the Company shall remain liable for such payments. 
 9.17. Adjustments in Share Numbers and
Prices. In the event of any stock split, reverse stock split, subdivision, combination, dividend, distribution, reorganization, recapitalization or other similar event affecting or relating to any of the Securities or Common Stock (or other
securities or rights convertible or exercisable into or exchangeable for or entitling the holder thereof to receive directly or indirectly, Securities or Common Stock), occurring on or after the date hereof, each reference in any Transaction
Document to a number of securities or a price per security shall be amended to appropriately account for such event. 
 9.18.
Acknowledgement. The Company acknowledges that, notwithstanding anything in this Agreement to the contrary, the representations, warranties, covenants and agreements of the Company contained in this Agreement shall not be deemed waived by any
investigation by Investor or any of its Associated Persons. The rights and remedies of the parties shall not be affected by any investigation conducted with respect to, or any knowledge acquired (or capable of being acquired) at any time, whether
before or after the execution and delivery of any of the Transaction Documents, with respect to the accuracy or inaccuracy of or compliance with any representation, warranty, covenant, or agreement. 

  
 27 

 [REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 

  
 28 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

			
	Company:
	
	EVERYWARE GLOBAL, INC.
		
	 By:
	 	 /s/ Sam A. Solomon

		 	Name:  Sam A. Solomon
		 	Title:     Chief Executive Officer

 [Signature page to Securities Purchase Agreement] 

 
			
	Investors:
	
	MONOMOY CAPITAL PARTNERS, L.P.
		
	 By:
	 	Monomoy General Partner, L.P.
	 Its:
	 	General Partner
		
	 By:
	 	Monomoy Ultimate GP, LLC
	 Its:
	 	General Partner
		
	 By:
	 	 /s/ Justin Hillenbrand

	 Name: Justin Hillenbrand

	 Its: Partner

	
	 Address: c/o Monomoy Capital Management, L.P.

	 142 West 57th Street, 17th floor

	 New York, NY 10019

	 Number of Preferred Shares: 13,071.354

	 Number of Warrant Shares: 2,736,354

	 Purchase Price: $12,331,466.04

	
	MCP SUPPLEMENTAL FUND, L.P.
		
	 By:
	 	Monomoy General Partner, L.P.
	 Its:
	 	General Partner
		
	 By:
	 	Monomoy Ultimate GP, LLC
	 Its:
	 	General Partner
		
	 By:
	 	 /s/ Justin Hillenbrand

	 Name: Justin Hillenbrand

	 Its: Partner

	
	 Address: c/o Monomoy Capital Management, L.P

	 142 West 57th street, 17th floor

	 New York, NY 10019

	 Number of Preferred Shares: 406.361

	 Number of Warrant Shares: 85,067

	 Purchase Price: $383,359.43

 [Signature page to Securities Purchase Agreement] 

 
			
	MCP EXECUTIVE CO-INVESTMENT FUND, L.P.
		
	 By:
	 	Monomoy General Partner, L.P.
	 Its:
	 	General Partner
		
	 By:
	 	Monomoy Ultimate GP, LLC
	 Its:
	 	General Partner
		
	 By:
	 	 /s/ Justin Hillenbrand

	 Name: Justin Hillenbrand

	 Its: Partner

	
	 Address: c/o Monomoy Capital Management, L.P

	 142 West 57th Street, 17th floor

	 New York, NY 10019

	 Number of Preferred Shares: 67.672

	 Number of Warrant Shares: 14,167

	 Purchase Price: $63,842.51

	
	 MONOMOY CAPITAL PARTNERS II, L.P.

		
	 By:
	 	Monomoy General Partner II, L.P.
	 Its:
	 	General Partner
		
	 By:
	 	Monomoy Ultimate GP, LLC
	 Its:
	 	General Partner
		
	 By:
	 	 /s/ Justin Hillenbrand

	 Name: Justin Hillenbrand

	 Its: Partner

	
	 Address: c/o Monomoy Capital Management, L.P

	 142 West 57th street, 17th floor

	 New York, NY 10019

	 Number of Preferred Shares: 7,419.617

	 Number of Warrant Shares: 1,553,221

	 Purchase Price: $6,999,638.98

 [Signature page to Securities Purchase Agreement] 

 
			
	MCP SUPPLEMENTAL FUND II, L.P.
		
	 By:
	 	Monomoy General Partner II, L.P.
	 Its:
	 	General Partner
		
	 By:
	 	Monomoy Ultimate GP, LLC
	 Its:
	 	General Partner
		
	 By:
	 	 /s/ Justin Hillenbrand

	 Name: Justin Hillenbrand

	 Its: Partner

	
	 Address: c/o Monomoy Capital Management, L.P

	 142 West 57th Street, 17th floor

	 New York, NY 10019

	 Number of Preferred Shares: 234.996

	 Number of Warrant Shares: 49,194

	 Purchase Price: $221,694.34

 [Signature page to Securities Purchase Agreement] 

 Exhibit A 

Certificate of Designation of Series A Preferred Stock 

 Exhibit A 

CERTIFICATE OF DESIGNATION 

SERIES A SENIOR REDEEMABLE 

PREFERRED STOCK 
 EVERYWARE GLOBAL,
INC. 
 The undersigned, a duly authorized officer of EveryWare Global, Inc., a Delaware corporation (the “Corporation”),
hereby certifies that the following resolution was duly adopted by the Board of Directors of the Corporation (the “Board of Directors”) in accordance with Section 151 of the General Corporation Law of the State of Delaware and
pursuant to the authority conferred upon the Board of Directors by the Third Amended and Restated Certificate of Incorporation of the Corporation dated May 21, 2013 (the “Certificate of Incorporation”): 

RESOLVED, that the Corporation be, and it hereby is, authorized to issue a new series of preferred stock, par value $0.0001 per share, as
Series A Senior Redeemable Preferred Stock, with an initial value upon liquidation (“Liquidation Value”) upon issuance on July 30, 2014 (the “Issue Date”), in the aggregate, of up to $21,200,000 and does hereby
in this Certificate of Designation (this “Certificate of Designation”) establish and fix and herein state and express the following designations, powers, preferences and rights: 

1. Designation and Number. A series of preferred stock of the Corporation, par value $0.0001 per share (“Preferred
Stock”), designated the Series A Senior Redeemable Preferred Stock (the “Series A Preferred Stock”), hereby is established. The number of shares of Series A Preferred Stock shall be 21,200. 

2. Rank. The Series A Preferred Stock ranks, with respect to rights to the payment of dividends and the distribution of assets in the
event of a Liquidation Event (as defined in Section 4), senior to all classes or series of common stock, par value $0.0001 per share (the “Common Stock”), of the Corporation, and senior to all other equity securities of
the Corporation. 
 3. Dividends. 

a. Commencing on the Issue Date, whether or not declared by the Board of Directors and whether or not there are funds legally available for
the payment of dividends, cumulative dividends on each share of Series A Preferred Stock shall accrue on a daily basis in arrears at the rate of 15% per annum, compounded quarterly, on the then existing Liquidation Value thereof as of the most
recent Dividend Payment Date. Dividends shall be payable quarterly in arrears on February 1, May 1, August 1 and November 1 of each year (a “Dividend Payment Date”), beginning with August 1, 2014.
Prior to the date (the “Repayment Date”) on which the Corporation has fully repaid or otherwise discharged all its payment obligations, subject to any Reinstatement (as defined below) but excluding any contingent indemnification
obligations not yet due and payable, under that certain Term Loan Agreement dated as of May 21, 2013 (as amended from 

 
time to time and not including any amendment in the nature of an extension or any refinancing of the indebtedness thereunder or pursuant thereto, the “Term Loan Agreement”),
among Anchor Hocking, LLC, Oneida Ltd., Universal Tabletop, Inc., Deutsche Bank Securities Inc., Jefferies Finance LLC, Deutsche Bank AG, New York Branch and various lenders from time to time, dividends shall not be paid in cash and all amounts due
on a share of Series A Preferred Stock shall be added to the Liquidation Value thereof. From and after the Repayment Date, dividends accruing from and after the Repayment Date shall be declared and paid in cash on the applicable Dividend Payment
Date; provided, however, that if any payments made under the Term Loan Agreement are required to be rescinded or otherwise restored, whether as a result of any proceedings in bankruptcy or reorganization or otherwise (each such event,
a “Reinstatement”), then for so long as the amounts of any such payments remain unsatisfied to the lenders under the Term Loan Agreement, the Repayment Date will be deemed to be suspended and no dividends shall be declared and paid
in cash. Any dividends not declared and paid in cash for any reason on the applicable Dividend Payment Date, whether before, on or after the Repayment Date and whether before or following any Reinstatement, shall be added to the Liquidation Value on
such Dividend Payment Date. Dividends payable for any period shall cumulate on a day-to-day basis and shall be computed on the basis of a 360-day year of twelve 30-day months and the actual number of days elapsed. 

b. Prior to the Repayment Date, no dividends will be declared and paid or declared and set apart for payment on any shares of Common Stock or
other equity securities of the Corporation, including Preferred Stock, ranking junior to the Series A Preferred Stock as to dividends and as to the distribution of assets upon the occurrence of a Liquidation Event (“Junior
Securities”). 
 c. From and after the Repayment Date, no dividends will be declared and paid or declared and set apart for payment
on any Junior Securities for any period unless full cumulative dividends have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof is irrevocably set apart for such payment on the Series A
Preferred Stock for all past dividend periods. 
 4. Liquidation Value. 

a. On any date, the “Liquidation Value” per share of Series A Preferred Stock is an amount equal to the sum of
(i) $1,000, plus (ii) all accrued and unpaid dividends thereon through such date, minus (iii) the amount of any dividends thereon actually declared and paid to the holders of Series A Preferred Stock in cash, which
dividends previously increased the amount of such Liquidation Value pursuant to clause (ii) above. 
 b. Upon any voluntary or
involuntary liquidation, dissolution, Change of Control or winding up of the affairs of the Corporation (a “Liquidation Event”), before any distribution or payment shall be made to the holders of Junior Securities, the holders of
the Series A Preferred Stock shall be entitled to be paid out of the assets of the Corporation available for distribution to its stockholders, an amount in cash equal to the Liquidation Value. Such amount shall be payable on the date of such
Liquidation Event. 

  
 2 

 c. “Change of Control” means the occurrence after the Issue Date of any of the
following events: (i) the acquisition by any individual or “group” as defined under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (other than Monomoy Capital Management,
L.P. or its Affiliated Companies (as defined in the Certificate of Incorporation)), of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition
transactions of stock of the Corporation entitling that individual or group to exercise more than 50% of the total voting power of all stock of the Corporation entitled to vote generally in the election of the Corporation’s directors (except
that such individual or group will be deemed to have beneficial ownership of all securities that such person has the right to acquire, whether such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition);
(ii) the amalgamation, consolidation, conversion or merger of the Corporation with or into any other corporation, company, business concern, firm, trust, other entity or person (each, a “Person”), other than any such
amalgamation, consolidation, conversion or merger in which the stockholders of the Corporation immediately prior to such amalgamation, consolidation, conversion or merger continue to hold at least a majority of the voting power of such Person in
substantially the same proportions immediately after such amalgamation, consolidation, conversion or merger; (iii) the sale, lease, transfer, license or conveyance of all or substantially all of the business or assets of the Corporation; or
(iv) the recapitalization or reorganization of or otherwise involving the Corporation, other than any such recapitalization or reorganization in which the stockholders of the Corporation immediately prior to such recapitalization or
reorganization continue to hold at least a majority of the voting power in the Corporation or any successor Person resulting from such recapitalization or reorganization in substantially the same proportions immediately after such recapitalization
or reorganization. 
 d. If, upon any such Liquidation Event, the net assets of the Corporation distributable among the holders of all
outstanding shares of the Series A Preferred Stock shall be insufficient to permit the payment in full to such holders of the preferential amounts to which they are entitled, then the entire net assets of the Corporation shall be distributed among
the holders of the Series A Preferred Stock ratably in proportion to the full amounts to which they would otherwise be respectively entitled. 

5. Redemption. 
 a.
Unless prohibited by Delaware law with respect to distributions to stockholders, the Corporation may, at its option, subject to the notice requirements below, redeem shares of Series A Preferred Stock, in whole or in part, at any time or from time
to time, for cash at a redemption price equal to 105% of the Liquidation Value of such shares. 

  
 3 

 b. The written notice shall be sent by or on behalf of the Corporation, by first class mail,
postage prepaid, to the holders of record of the shares of Series A Preferred Stock to be redeemed at their respective addresses as they shall appear on the records of the Corporation, not less than 60 days prior to the date of redemption
(i) notifying such holders of the election of the Corporation to redeem such shares of Series A Preferred Stock and of the date of redemption, and (ii) stating the place or places at which the shares of Series A Preferred Stock called for
redemption shall, upon presentation and surrender of the certificates evidencing such shares of Series A Preferred Stock, be redeemed, and the redemption price therefor. 

6. Voting Rights. 
 a.
Holders of the Series A Preferred Stock will not have any voting rights, except as set forth below in Section 6(b). 
 b.
Without the prior consent of the holders of at least a majority of the shares of Series A Preferred Stock then outstanding, given in writing or by vote at a meeting of stockholders called for such purpose, the Corporation will not: 

(i) authorize, create or issue, or increase the number of authorized or issued shares of, any Series A Preferred Stock or any other class or
series of Preferred Stock; 
 (ii) authorize, create or issue, or increase the number of authorized or issued shares of, any other capital
stock of the Corporation of any class or series, except for Common Stock; 
 (iii) either (A) declare or pay (or declare and set aside
for payment of) any dividend or make any distribution on or in respect of any class or series of stock of the Corporation, whether in cash, property or otherwise, or (B) purchase or redeem, or permit any subsidiary of the Company to purchase or
redeem, any Junior Security, or pay or make available any monies for a sinking fund for the purchase or redemption of any Junior Security; 

(iv) amend, alter or repeal any of the provisions of the Certificate of Incorporation, including the terms of the Series A Preferred Stock,
the by-laws of the Corporation or the charter or by-laws of any subsidiary of the Corporation; 
 (v) enter into any transaction or series
of transaction that would result in a Change of Control; 
 (vi) amalgamate, consolidate, convert or merge with another Person, or enter
into or form any partnership or joint venture or acquire any shares of stock or other equity securities in any other Person; or 
 (vii)
authorize or adopt any stock option, stock incentive or other equity incentive plan (each, an “Equity Plan”); increase the number of options or securities (including equity-like and phantom equity securities) available for grant or

  
 4 

 
issuance under any Equity Plan; grant any allocation of options or securities (including equity-like and phantom equity securities) under any Equity Plan; amend or supplement any Equity Plan; or
authorize or issue any options or securities (including equity-like and phantom equity securities) that are in the nature of incentive compensation outside of an Equity Plan. 

provided, however, that during the continuance of an Event of Default (as defined in the Term Loan Agreement), which has not been either waived
or cured, no such prior consent of the holders of at least a majority of the shares of Series A Preferred Stock then outstanding shall be required for any the items set forth above in this Section 6(b). 

7. Information Rights. For so long as any shares of Series A Preferred remain outstanding, the Corporation shall furnish to each holder
of shares of Series A Preferred: 
 a. promptly after the same are available and in any event within 120 days after the end of each fiscal
year of the Corporation, (i) the annual operating budget of the Corporation as approved by the Board of Directors, and (ii) audited financial statements for the Corporation, including, but not limited to, statements of income and
stockholders’ equity and cash flow from the beginning of such fiscal year to the end of such fiscal year and the balance sheet as at the end of such fiscal year, all prepared in accordance with GAAP applied on a basis consistent with prior
practices, and in reasonable detail, and accompanied by an opinion thereon of an independent certified public accounting firm selected by the Corporation, which opinion shall state that such statements present fairly, in all material respects, the
financial position of the companies being reported upon and their results of operations and cash flows and have been prepared in accordance with GAAP; provided, however, that to the extent that the Corporation timely files the
information required by clause (ii) of this Section 7.a. with the United States Securities and Exchange Commission in compliance with applicable securities laws, the Corporation shall be deemed to have satisfied the requirements of
such clause (ii). 
 b. promptly after the same are available and in any event within 45 days after the end of each fiscal quarter of
the Corporation, unaudited financial statements for the Corporation, including, but not limited to, (i) statements of income and stockholders’ equity and cash flow from the beginning of such fiscal quarter to the end of such fiscal quarter
and from the beginning of the applicable fiscal year to the end of such fiscal quarter and (ii) the balance sheet as at the end of such fiscal quarter, all prepared in accordance with GAAP applicable to interim financial statements generally
and applied on a basis consistent with prior practices and complete and correct in all material respects, subject to normal and recurring year-end adjustments and recognizing that such statements need not contain footnotes similar in nature to the
footnotes contained in any annual financial statement. Such quarterly financial statements shall set forth a comparison of the figures for the current fiscal period and the current year-to-date period, with the figures for the same fiscal period and
year-to-date period of the immediately preceding fiscal year; provided, however, that to the extent that the Corporation timely files the information required by this Section 7.b. with the United States Securities and
Exchange Commission in compliance with applicable securities laws, the Corporation shall be deemed to have satisfied the requirements of such Section 7.b.. 

  
 5 

 c. promptly after the same are provided to the Board of Directors (or any executive committee
thereof), (i) monthly operating financial reports of the Corporation, including without limitation all operating financial information provided and flash reports by segment (which shall include without limitation gross sales, operating margins
and similar information for such period), and (ii) unaudited financial statements for the Corporation including, but not limited to, (A) statements of income and stockholders’ equity and cash flow for such month and from the beginning
of the applicable fiscal year to the end of such month; and (B) the balance sheet as at the end of such month, all prepared in accordance with GAAP applicable to interim financial statements generally and applied on a basis consistent with
prior practices and complete and correct in all material respects, subject to normal and recurring year-end adjustments and recognizing that such statements need not contain footnotes similar in nature to the footnotes contained in any annual
financial statement. Such monthly financial statements shall set forth a comparison of the figures for the current fiscal period and the current year-to-date period, with the figures for the same fiscal period and year-to-date period of the
immediately preceding fiscal year; and 
 d. any additional information as may be reasonably requested by the holders of shares of
Series A Preferred Stock. 
 8. Status of Redeemed and Reacquired Shares of Series A Preferred Stock. If any shares of Series A
Preferred Stock shall be redeemed pursuant to Section 5, or otherwise reacquired by the Corporation, the shares so redeemed or reacquired shall become authorized but unissued shares of Preferred Stock, without designation as to series or
class and available for future issuance and reclassification by the Corporation. 
 9. Short Sales. By acceptance of any shares of
Series A Preferred Stock, each holder thereof agrees that, for so long as such holder remains a holder of Series A Preferred Stock, such holder shall not engage in any Short Sales of the Common Stock. “Short Sales” means all
“short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act. 
 10. Severability. If any
preference, voting power, restriction, limitation as to dividends or other distributions, qualification, term or condition of redemption or other term of the Series A Preferred Stock is invalid, unlawful or incapable of being enforced by reason of
any rule of law or public policy, then, to the fullest extent permitted by law, all other preferences, voting powers, restrictions, limitations as to dividends, qualifications, terms or conditions of redemption and other terms of the Series A
Preferred Stock which can be given effect without the invalid, unlawful or unenforceable preference, voting power, restriction, limitation as to dividends or other distributions, qualification, term or condition of redemption or other term of the
Series A Preferred Stock shall remain in full force and effect and shall not be deemed dependent upon any other such preference, voting power, restriction, limitation as to dividends or other distributions, qualification, term or condition of
redemption or other term of the Series A Preferred Stock unless so expressed herein. 

  
 6 

 IN WITNESS WHEREOF, the undersigned, being duly authorized, does hereby affirm that this
Certificate of Designation is the act and deed of the Corporation and the facts stated herein are true, and accordingly has hereunto set his hand as of this 30th day of July, 2014. 

 

			
	EVERYWARE GLOBAL, INC.
		
	 By:
	 	 /s/ Sam Solomon

		 	Sam Solomon
		 	Chief Executive Officer

  
 7 

 Exhibit B 

Form of Warrant 

 Exhibit B 

FORM OF WARRANT 
 THIS SECURITY, AS WELL
AS THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY, HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS SECURITY, AS WELL AS THE COMMON STOCK OF
THE COMPANY UNDERLYING THIS SECURITY, MAY NOT BE OFFERED FOR SALE, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED (I) IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, (II) IN THE ABSENCE OF AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS, AS EVIDENCED (IF REQUIRED BY THE COMPANY) BY A LEGAL OPINION
OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT, OR (III) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER
REPRESENTATION LETTER AND A BROKER REPRESENTATION LETTER, IN EITHER CASE AS MAY BE APPLICABLE) THAT THE SECURITIES MAY BE SOLD PURSUANT TO SUCH RULE). NO REPRESENTATION IS MADE BY THE COMPANY AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE
144 UNDER THE SECURITIES ACT FOR RESALES OF THIS SECURITY, OR THE COMMON STOCK OF THE COMPANY UNDERLYING THIS SECURITY 
 EVERYWARE
GLOBAL, INC. 
 WARRANT 
  

			
	Warrant No. [    ]	 	Dated: July 30, 2014

 EVERYWARE GLOBAL, Inc., a Delaware corporation (the “Company”), hereby certifies that, for
value received, [Name of Holder] or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of
[                    ] shares of common stock, $0.0001 par value per share (the “Common Stock”), of the Company (each
such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an initial exercise price equal to $0.01 per share, at any time during the period (the “Exercise Period”) commencing on
the date hereof and terminating at 5:00 p.m., New York City time on July 30, 2021 (the “Expiration Date”). This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain
Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the Investors identified therein (the “Purchase Agreement”). All such warrants are referred to herein, collectively, as the
“Warrants.” The term “Warrant Price” as used in this Warrant shall mean the exercise price per share at which Common Stock may be purchased at the time a Warrant is exercised. The Warrant Price and the number of
Warrant Shares may be adjusted from time to time in accordance with Section 5. 

 1. Definitions. In addition to the terms defined elsewhere in this Warrant, capitalized
terms that are not otherwise defined herein have the respective meanings given to such terms in the Purchase Agreement. 
 2.
Registration of Warrant. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Warrant
Register also shall set forth the address of the record Holder, as provided by such record Holder to the Company. The Company may deem and treat the registered Holder of record of this Warrant as the absolute owner hereof for the purpose of any
exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary. The Company shall register in the Warrant Register.the exercise (pursuant to Section 4) or the transfer (pursuant to
Section 6) of all or any portion of this Warrant. 
 3. Duration of Warrants. This Warrant may be exercised only during
the Exercise Period commencing on the date hereof and terminating at 5:00 p.m., New York City time on the Expiration Date. Each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in
respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, that the
Company shall provide at least 20 days’ prior written notice of any such extension to Registered Holders of the Warrants; provided further that any such extension shall be identical in duration among all the Warrants and the warrants
issued to the lenders (the “Lender Warrants”) under the Company’s term loan pursuant to the Waiver and Amendment No. 1 dated as of July 30, 2014, to the Term Loan Agreement dated as of May 21, 2013, among Anchor
Hocking, LLC, Oneida Ltd., Universal Tabletop, Inc., Deutsche Bank Securities Inc., Jefferies Finance LLC Deutsche Bank AG, New York Branch and various lenders from time to time party thereto entered into concurrently with the execution of the
Purchase Agreement. 
 4. Exercise of Warrants and Issuance of Warrant Shares 

(a) Exercise. This Warrant may be exercised by the Holder hereof by surrendering it to the Company, with an exercise notice, in the
form attached hereto (the “Exercise Notice”), appropriately completed and duly executed, and by paying in full the Warrant Price for each full Warrant Share as to which this Warrant is exercised as follows: 

(i) with respect to the exercise of any Warrant on a “cash basis”, by wire transfer of immediately available funds,
in good certified check or good bank draft payable to the order of the Company; provided, that the Holder provides the information on the Exercise Notice that is reasonably necessary for the Company to issue the Warrant Shares in compliance
with U.S. federal securities law; or 
 (ii) with respect to the exercise of any Warrant on a “cashless basis” by
surrendering such Warrant for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying such Warrant or any portion thereof being exercised (at the
election of the Holder), multiplied by the difference between the Fair Market Value and the Warrant 

  
 2 

 
Price by (y) the Fair Market Value. “Fair Market Value” means (A) at any time the Common Stock is listed or quoted for trading on the New York Stock Exchange, the New
York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market, OTC Bulletin Board or any other national securities exchange (each, an “Exchange”), the average last sale price
of a share of Common Stock for the ten trading days ending on the third trading day prior to the date on which notice of exercise of such Warrant is sent to the Company (the “Exercise Date”); or (B) at any time the Common Stock
is not listed or quoted for trading on an Exchange, the fair market value of a share of Common Stock as shall be determined by the Board of Directors of the Company (the “Board”) in its good faith judgment; 

provided, however, that notwithstanding the foregoing, the issuance of shares of Common Stock or other securities upon the
exercise of any Warrant shall be made without charge to the Holder for any issue or other tax in respect thereof; provided further, however if at any time the Common Stock is not a “covered security” under Section 18(b) of the
Securities Act, the Company may, at its option, require any exercise of Warrants to be made on a “cashless basis.” 
 (b)
Issuance of Common Stock on Exercise. As soon as practicable after the exercise of this Warrant and the clearance of the funds in payment of the Warrant Price (if payment is on a “cash basis” pursuant to
Section 4(a)(i)), the Company shall issue to the Holder of such Warrant a certificate or certificates for the number of full shares of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed
by him, her or it, and if such Warrant shall not have been exercised in full, a new warrant to purchase Common Stock, of like tenor, having the same date and form as this Warrant and otherwise having the same terms and conditions as this Warrant
(any such new warrant, a “New Warrant”), for the number of Warrant Shares as to which such Warrant shall not have been exercised. The Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof
are absolute and unconditional. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon exercise of any Warrant as required pursuant to the terms hereof. 

(c) Valid Issuance. All Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly
issued, fully paid and nonassessable, and free and clear of all Liens. For purposes hereof, “Lien” means any mortgage, lien (statutory or otherwise), charge, pledge, hypothecation, conditional sales agreement, adverse claim, title
retention agreement or other security interest, encumbrance or other title defect in or on any interest or title of any vendor, lessor, lender or other secured party to or of such person or entity under any conditional sale, trust receipt or other
title retention agreement with respect to any property or asset of such person or entity. At any time that the Warrants are outstanding, the Company shall cause to be maintained all authorizations required for the issuance of a number of shares of
Common Stock which the Company may be liable to issue upon exercise of the Warrants from time to time remaining outstanding, in accordance with the terms and conditions this Warrant. All shares of Common Stock delivered upon exercise of the Warrants
shall be 

  
 3 

 
newly issued shares or shares held in treasury by the Company, shall have been duly authorized and validly issued and shall be fully paid and non-assessable and free of any Lien and shall not be
subject to any preemptive rights or similar rights and shall rank pari passu in all respects with other existing Common Stock. 
 (d)
Date of Issuance. Each person or entity in whose name any certificate for Common Stock is issued shall for all purposes be deemed to have become the holder of record of such Common Stock on the date on which the Warrant was surrendered and
payment of the Warrant Price was made, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is a date when the share transfer books of the Company are closed, such person or entity shall be
deemed to have become the holder of such shares at the close of business on the next succeeding date on which the share transfer books are open. The Company shall, upon request of the Holder, use its reasonable best efforts to cause the ownership of
the Warrant Shares to be recorded upon exercise in book entry form rather than through the issuance of physical stock certificates (provided that such book entry interests will continue to bear any required restrictive legends). 

(e) Issuance Limits. Notwithstanding the foregoing, unless and until the Company obtains any stockholder approval required by NASDAQ
Listing Rule 5635 to permit full exercisability of the Warrants, the number of shares of Common Stock for which the Warrants will be exercisable will be limited to the number of shares of Common Stock that, when taken to together with all shares of
Common Stock issued or issuable upon exercise of the Lender Warrants, would be equal to 19.9% of the outstanding shares of the Common Stock as of the date of this Warrant. 

(f) Listing of Warrant Shares. In the time and manner required by any Exchange on which the Common Stock is listed or quoted for
trading on the date in question (the “Trading Market”), the Company shall prepare and file with such Trading Market additional shares listing application covering all the Common Stock issuable upon exercise of the Warrants and shall
use its reasonable best efforts to take all steps necessary to cause all of the Common Stock issuable upon exercise of the Warrants to be approved for listing on the Trading Market at all times. 

5. Certain Adjustments. The number of Warrant Shares issuable upon exercise of this Warrant, as well as the Warrant Price, is subject
to adjustment from time to time as set forth in this Section 5. 
 (a) Split-Ups. If after the date hereof, the number of
outstanding shares of Common Stock is increased by a stock dividend payable in Common Stock, or by a split-up or sub-division of Common Stock or other similar event, then, on the effective date of such stock dividend, split-up, sub-division or
similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock, subject to the provisions of Section 5(g). 

(b) Other Distributions. If after the date hereof, the Company makes a distribution (a “Distribution”) to the holders
of its Common Stock (other than in connection with the liquidation, dissolution or winding up of the Company) of any asset (including cash or 

  
 4 

 
evidence of its indebtedness) or security (including any subscription right) (the total value of the assets or securities so distributed, the “Distribution Amount”) other than a
distribution referred to in Section 5(a), then the Company shall distribute to the holder of each Warrant the portion of the Distribution Amount which a holder of the number of shares of Common Stock for which such Warrant is exercisable
immediately prior to the Distribution would have owned or received immediately after and as a result of such Distribution. 
 (c)
Aggregation of Shares. If after the date hereof, the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of Common Stock or other similar event, then, on the
effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding
Common Stock, subject to the provisions of Section 5(g). 
 (d) Replacement of Securities upon Reorganization, etc. In
case of any recapitalization, reclassification or reorganization of the outstanding Common Stock (other than a change under Section 5(a), Section 5(b) or Section 5(c) or that solely affects the par value of such
Common Stock), or in the case of any amalgamation, conversion, merger or consolidation of the Company with or into another corporation or other entity (other than a consolidation or merger in which the Company is the continuing corporation and that
does not result in any recapitalization, reclassification or reorganization of the outstanding Common Stock), or in the case of any sale, lease, license, transfer or conveyance to another corporation or entity of the assets or other property of the
Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, liquidated or wound up, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms
and conditions specified in the Warrants and in lieu of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other
securities or property (including cash) receivable upon such recapitalization, reclassification, reorganization, amalgamation, conversion, merger or consolidation, or upon a dissolution, liquidation or winding up following any such sale, lease,
license, transfer or conveyance, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”); provided,
however, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such amalgamation, conversion, merger or consolidation, or
upon a dissolution, liquidation or winding up following any such sale, lease, license, transfer or conveyance, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become
exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such amalgamation, conversion, merger or consolidation, or upon a dissolution, liquidation or winding up following
any such sale, lease, license, transfer or conveyance, that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock under circumstances in
which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of
which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of 

  
 5 

 
which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the outstanding Common Stock, the holder of a Warrant
shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the
expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or
exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 5. If any recapitalization, reclassification or reorganization also results in a change in Common Stock covered by both
Section 5(a) or Section 5(c) and this Section 5(d), then such adjustment shall be made pursuant to both Section 5(a) or Section 5(c) and this Section 5(d). The provisions of
this Section 5(d) shall similarly apply to successive recapitalizations, reclassifications, reorganizations, amalgamations, conversions, mergers or consolidations, sales, leases, licenses, transfers, conveyances and other similar
transactions, and the Company shall not effect any such transaction unless, prior to the consummation thereof, the successor person or entity (if other than the Company) resulting from such transaction, shall assume, by written instrument
substantially similar in form and substance to this Warrant and reasonably satisfactory to the majority in interest of the Holders, the obligation to deliver to the Holder such shares of stock, securities or assets which, in accordance with the
foregoing provisions, such Registered Holder shall be entitled to receive upon exercise of the Warrants held by them. Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction contemplated by
the provisions of this Section 5(d), the Holder shall have the right to elect prior to the consummation of such event or transaction, to give effect to the exercise rights contained herein instead of giving effect to the provisions
contained in this Section 5(d) with respect to the Warrants. 
 (e) Warrant Price Adjustment. Whenever the number of
shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in Section 5(a) or Section 5(c), the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price
immediately prior to such adjustment by a fraction (i) the numerator of which shall be the number of Warrant Shares purchasable upon the exercise of this Warrant immediately prior to such adjustment, and (ii) the denominator of which shall
be the number of Warrant Shares so purchasable immediately thereafter. 
 (f) Notices of Changes in Warrant. Upon every adjustment of
the Warrant Price or the number of Warrant Shares issuable upon exercise of this Warrant, the Company shall give prompt written notice thereof to the Holder, which notice shall state the increase or decrease, if any, in the Warrant Price resulting
from such adjustment and the increase or decrease, if any, in the number of Warrant Shares purchasable at the Warrant Price, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the
occurrence of any event specified in Sections 5(a), 5(b), 5(c) or 5(d), the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in
the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event. In the event: (i) that the Company shall take a record of
the holders of its Common Stock (or other capital stock or securities at the time issuable upon exercise of the Warrant) for the purpose of entitling or enabling them to receive any dividend or other

  
 6 

 
distribution, to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities, or to receive any other security; (ii) of any
recapitalization or reorganization of the Company, any reclassification of the Common Stock of the Company, any amalgamation, conversion, consolidation or merger of the Company with or into another person or entity, or sale, lease, license, transfer
or conveyance of all or substantially all of the Company’s assets to another person or entity; or (iii) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company; then, and in each such case, the Company shall
send or cause to be sent to the Holder at least 20 days prior to the applicable record date or the applicable expected effective date, as the case may be, for the event, a written notice specifying, as the case may be, (A) the record date for
such dividend, distribution, or other right, and a description of such dividend, distribution or other right to be taken at such meeting or by written consent, or (B) the effective date on which such reorganization, reclassification,
amalgamation, conversion, consolidation, merger, sale, lease, license, transfer, conveyance, dissolution, liquidation or winding-up is proposed to take place, and the date, if any is to be fixed, as of which the books of the Company shall close or a
record shall be taken with respect to which the holders of record of Common Stock (or such other capital stock or securities at the time issuable upon exercise of this Warrant) shall be entitled to exchange their shares of Common Stock (or such
other capital stock or securities) for securities or other property deliverable upon such recapitalization, reorganization, reclassification, amalgamation, conversion, consolidation or merger, sale, dissolution, liquidation or winding-up, and the
amount per share and character of such exchange applicable to this Warrant and the Warrant Shares. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event. 

(g) No Fractional Shares. Notwithstanding any provision contained herein to the contrary, the Company shall not issue fractional shares
upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 5, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall,
upon such exercise, at its option either (i) round up to the nearest whole number, the number of shares of Common Stock to be issued to such holder or (ii) in lieu of such fractional share interests, pay to such holder an amount in cash
equal to the product obtained by multiplying (x) the fractional share interest to which such holder would otherwise be entitled by (y) the Fair Market Value on the exercise date. 

(h) No Change to Warrant. This Warrant need not be changed because of any adjustment pursuant to Section 5. 

(i) Other Events. If any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this
Section 5 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this
Section 5, then the Board shall make an appropriate adjustment in the Warrant Price and the number of shares of Common Stock issuable upon exercise of this Warrant so as to protect the rights of the Holder in a manner consistent with the
provisions of this Section 5; provided, that no such adjustment pursuant to this Section 5(i) shall increase the Warrant Price or decrease the number of shares of Common Stock issuable as otherwise determined pursuant to this
Section 5. 

  
 7 

 (j) Other Warrants. In no event will any adjustment, comparable to those in this
Section 5, be made to the Lender Warrants unless such adjustment is made pursuant to this Section 5 on the same terms to all outstanding Warrants. The immediately preceding sentence shall not be in limitation of, or otherwise
affect, the other provisions of this Section 5. 
 6. Transfers. 

(a) Assignment Form; Registration. This Warrant may be offered for sale, sold, transferred or assigned without the consent of the
Company, subject to Section 6(b). The Company shall register the transfer, from time to time, of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, with the Form of Assignment attached hereto duly
completed and signed (each, an “Assignment Form”), to the Company at its address specified herein. Upon any such registration of transfer, a New Warrant evidencing the portion of this Warrant so transferred shall be issued to the
transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of any New Warrant by the transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations of a holder of a Warrant. 
 (b) Opinion. In connection with any such transfer, upon
reasonable request by the Company to such transferring Holder at the expense of such Holder, such Holder will give to the Company an opinion of counsel (which may be in-house counsel or outside counsel to such Holder or its investment adviser) in
form and substance reasonably satisfactory to the Company to the effect that the proposed transfer of such Warrant may be effected without registration or qualification of such Warrant under the Securities Act or any applicable state securities law.

 (c) Exchange of Warrants. This Warrant may be surrendered to the Company, together with a written request for exchange or transfer
into different denominations, and thereupon the Company shall issue in exchange therefor one or more New Warrants as requested by the Holder of this Warrant so surrendered, representing an equal aggregate number of Warrant Shares, registered in the
name of such surrendering holder. 
 (d) Fractional Warrants. The Company shall not be required to effect any registration of
transfer or exchange which shall result in the issuance of a fraction of a warrant. 
 (e) Service Charges. No service charge shall
be made for any exchange or registration of transfer of Warrants. 
 (f) Closing of Transfer Books. The Company will at no time close
its transfer books against the transfer of any Warrant in any manner which interferes with the timely exercise hereof. 
 7. Other
Provisions Relating to Rights of Holders of Warrants. 
 (a) No Rights as Stockholder; Limitation on Liability. A Warrant does
not entitle the Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends or other distributions (except as provided in Section 5), exercise any preemptive rights
to vote or to consent or to receive notice as 

  
 8 

 
stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter. No provisions hereof, in the absence of affirmative action by the Holder
to purchase shares of Common Stock, and no mere enumeration herein of the rights or privileges of any Holder, shall give rise to any liability of any Holder for the Warrant Price or as a stockholder of the Company, whether such liability is asserted
by the Company or by its creditors. 
 (b) Lost, Stolen, Mutilated, or Destroyed Warrants. If this Warrant is lost, stolen,
mutilated, or destroyed, the Company may on such terms as to indemnity or otherwise as it may in its reasonable discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a New Warrant of like
denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such New Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed
Warrant shall be at any time enforceable by anyone. 
 (c) Reservation of Common Stock. The Company shall at all times reserve and
keep available a number of its authorized but unissued Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants. 

(d) No Impairment. The Company will not, by amendment of its governing documents or through any recapitalization, reclassification,
reorganization, amalgamation, conversion, merger, consolidation, or through any sale, lease, license, transfer, conveyance of its assets, or through any other similar transactions, or through any dissolution, liquidation, winding up of the Company
or through issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Agreement, but will at all times in good faith assist in the carrying out of all such terms and in
the taking of all such action as may be necessary or appropriate in order to protect the rights of the Registered Holders against impairment. Without limiting the generality of the foregoing, the Company (i) will not increase the par value of
any shares of Common Stock issuable upon exercise of any Warrant above the amount payable therefor on such exercise, (ii) will take all such action as may be reasonably necessary or appropriate in order that the Company may validly and legally
issue fully paid and nonassessable shares Common Stock upon the exercise of this Warrant, and (iii) will not close its stockholder books or records in any manner which interferes with the timely exercise of this Warrant. 

8. Charges, Taxes and Expenses. The Company shall from time to time promptly pay any issue or transfer tax, withholding tax, transfer
agent fee or other incidental tax or expense that may be imposed upon the Company in respect of the issuance or delivery of Common Stock to the registered holder thereof upon the exercise of the Warrants, including such taxes imposed pursuant to
Section 4, but the Company shall not be obligated to pay any transfer taxes associated with transfers by the Holder of any Warrants or Warrant Shares. 

9. Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind
and inure to the benefit of their respective successors and assigns. The Company will not amalgamate, merge, convert or consolidate with or into, or sell, transfer, license or lease all or substantially all of its property or

  
 9 

 
assets to, any other party unless the successor, transferee, licencee or lessee party, as the case may be (if not the Company), assumes (expressly or by operation of law) the due and punctual
performance and observance of each and every covenant and condition of this Agreement and the Warrants to be performed and observed by the Company. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any person
or entity other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. 
 10.
Notices. All notices, statements or other documents which are required or contemplated by this Warrant (including without limitation the delivery of any Exercise Notice or Assignment Form, the surrender of this Warrant and the issuance of any
New Warrant) to be given, delivered or made by the Company or the hold of any Warrant to the other shall be in writing (each a “Notice”) and shall be: (a) delivered personally or by commercial messenger; (b) sent via a
recognized overnight courier service; (c) sent by registered or certified mail, postage pre-paid and return receipt requested; or (d) sent by facsimile transmission, provided confirmation of receipt is received by sender and the original
Notice is sent or delivered contemporaneously by an additional method provided in this Section 10; in each case so long as such Notice is addressed to the intended recipient thereof as set forth below: 

If to the Company: 

EveryWare Global, Inc. 

519 North Pierce Avenue 

Lancaster, OH 43130 

Attention: Chief Executive Officer 

                    
General Counsel 
 Facsimile: 740-681-6455 

If to the Holder: 

At its address set forth in the Warrant Register. 

Any party may change its address specified above by giving each party Notice of such change in accordance with this Section 10. Any Notice shall
be deemed given upon actual receipt (or refusal of receipt). 
 11. Applicable Law. The validity, interpretation, and performance of
this Warrant shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The Company hereby agrees
that any action, proceeding or claim against it arising out of or relating in any way to this Warrant shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and
irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. 

  
 10 

 12. Persons Having Rights under this Warrant. Nothing in this Warrant expressed and
nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the Holders of the Warrants any right, remedy, or claim under
or by reason of this Warrant or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Warrant shall be for the sole and exclusive benefit of the
parties hereto and their successors and assigns and of the Holders of the Warrants, each of whom are third party beneficiaries of this Warrant. 

13. Effect of Headings. The section headings herein are for convenience only and are not part of this Warrant and shall not affect the
interpretation thereof. 
 14. Amendment and Waiver. This Warrant may be amended by the Company without the consent of any Holder for
the purpose of curing any immaterial ambiguity, or curing, correcting or supplementing any immaterial defective provision contained herein. All other modifications or amendments, including any amendment to increase the Warrant Price, change the
number of shares of Common Stock issuable upon exercise of the Warrants or shorten the Exercise Period, shall require the written consent of the holders of then outstanding Warrants then exercisable into a majority of the shares of Common Stock
issuable upon exercise of all then outstanding Warrants. Notwithstanding the foregoing, the Company may extend the duration of the Exercise Period pursuant to Section 3 without the consent of the majority of the shares of Common Stock
issuable upon exercise of all then outstanding Warrants; provided, however, that any such extension also shall be applicable on the same terms to all the Warrants and the Lender Warrants. 

15. Miscellaneous. 
 (a)
This Warrant shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Warrant or of any other term or provision hereof. Furthermore, in lieu of any such
invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Warrant a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 (b) If the Company fails to perform, comply with or observe any covenant or agreement to be performed, complied with or observed by it
under this Warrant, the Holder may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term contained in this Warrant or for an injunction against the breach or threatened breach of
any such term or in aid of the exercise of any power granted in this Warrant or to enforce any other legal or equitable right, or to take any one or more of such actions. The Company hereby agrees that the Holder shall not be required or otherwise
obligated to, and hereby waives any right to demand that such Holder, post any performance or other bond in connection with the enforcement of its rights and remedies hereunder. The Company agrees to pay all reasonable fees, costs, and expenses,
including, without limitation, fees and expenses of attorneys, accountants and other experts retained by the Holder, and all reasonable fees, costs and expenses of appeals, incurred or expended by the Holder in connection with the enforcement of
this Warrant or the collection of any sums due hereunder, whether or not suit is commenced. 

  
 11 

 
None of the rights, powers or remedies conferred under this Warrant shall be mutually exclusive, and each right, power or remedy shall be cumulative and in addition to any other right, power or
remedy whether conferred by this Warrant or now or hereafter available at law, in equity, by statute or otherwise. 
 REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK, 
 SIGNATURE PAGE FOLLOWS 

  
 12 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized
officer as of the date first indicated above. 
  

			
	EVERYWARE GLOBAL, INC.
		
	 By: 
	 	  

 
			
	 Name: 
	 	  

 
			
	 Title: 
	 	  

  
 13 

 FORM OF EXERCISE NOTICE 

(To be executed by the Holder to exercise the right to purchase shares of Common Stock under the foregoing Warrant) 

To EveryWare Global, Inc.: 
 The undersigned is the Holder
of Warrant No.          (the “Warrant”) issued by EveryWare Global, Inc., a Delaware corporation (the “Company”), which accompanies this Exercise Notice. Capitalized terms
used herein and not otherwise defined have the respective meanings set forth in the Warrant. 
  

	1.	The Warrant is currently exercisable to purchase a total of                  Warrant Shares. 

 

	2.	The undersigned Holder hereby exercises its right to purchase                  Warrant Shares pursuant to the Warrant. 

 

	3.	The Holder intends that payment of the Warrant Price shall be made as (check one): 

             “Cash Basis” under Section 4(a)(i) 

             “Cashless Basis” under Section 4(a)(ii) 

 

	4.	If the holder has elected a Cash Exercise, the holder shall pay the sum of $             to the Company in accordance with the terms of the Warrant.

  

	5.	To the extent that the Holder intends the payment of the Warrant Price to be made on a “Cash Basis” (pursuant to Item 3 above), the Holder confirms to the Company the following checked representations and
agreements are true as of the date hereof: 

      It is acquiring Warrant Shares whose issuance
upon exercise of the Warrant has been registered on an effective registration statement under the Securities Act. 
 OR 

     It (A) is an “accredited investor” within the meaning of Rule 501(a)(1) under the Securities Act
OR (B) either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Warrant
Shares, and has so evaluated the merits and risks of such investment; AND 
      It is acquiring the Warrant
Shares for itself and does not intend to re-offer or re-sell the Warrant Shares in connection with a distribution; AND 

     It understands that each Warrant Share is characterized as “restricted security” under the U.S.
federal securities laws inasmuch as it is being acquired from the Company in a transaction not involving a public offering and that under U.S. federal securities laws and applicable regulations the Warrant Shares may be resold without registration
under the Securities Act only in certain limited circumstances; AND 

      It is understood that certificates evidencing the Warrant Shares
will bear any legend as required by the Blue Sky laws of any state and a restrictive legend in substantially the form set forth in the Purchase Agreement (as defined in the Warrant). 

 

	6.	Pursuant to this exercise, the Company shall deliver to the holder                  Warrant Shares in accordance with the terms of the
Warrant. 

  

	7.	Following this exercise, the Warrant shall be exercisable to purchase a total of             Warrant Shares. 

 

			
	 Dated:                     ,
        
	 	Name of Holder:
		
		 	(Print)                                    
                                         
                                       
		
		 	By:                                     
                                         
                                         
  
		 	Name:                                     
                                         
                                      
		 	Title:                                    
                                         
                                         

		
		 	 (Signature must conform in all respects to name of holder as specified on the face of the
Warrant)

  

	
	 ACKNOWLEDGED AND AGREED TO this      day of
                    , 201    
  

EVERYWARE GLOBAL, INC. 

	
	By:                                     
                                         
           
	Name:                                     
                                         
     
	Title:                                     
                                         
       

 FORM OF ASSIGNMENT 

[To be completed and signed only upon transfer of Warrant] 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                                        
the right represented by the within Warrant to purchase                  shares of Common Stock of EveryWare Global, Inc. to which the within Warrant relates and
appoints              attorney to transfer said right on the books of EveryWare Global, Inc. with full power of substitution in the premises. 

In connection with any transfer of this Warrant, the undersigned confirms that it has not utilized any general solicitation or general advertising in
connection with the transfer and is making the transfer pursuant to one of the following: 
 [Check One] 

(1)      to the Company; or 
 (2)
     to an “accredited investor” (as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”)); or 

(3)      pursuant to the exemption from registration provided by Rule 144 under the Securities Act or pursuant to another exemption
available under the Securities Act; or 
 (4)      Pursuant to an effective registration statement under the Securities Act. 

and unless the box below is checked, the undersigned confirms that such Warrant is not being transferred to an “affiliate” of the Company as defined
in Rule 144 under the Securities Act (an “Affiliate”): 
  

	 	 ̈	The transferee is an Affiliate of the Company. 

 Dated:
                    ,         

 

	
	  

	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
	
	  

	Address of Transferee
	
	  

	
	  

 

	
	In the presence of:
	
	  

 Exhibit C 

EVERYWARE GLOBAL, INC. 

OFFICER’S CERTIFICATE 

In connection with the issuance and sale by EveryWare Global, Inc., a Delaware corporation (the “Company”) of an aggregate of
21,200 shares of the Company’s Series A Preferred Stock, par value $0.0001 per share and warrants to purchase 4,438,004 shares of the Company’s common stock, par value $0.0001 per share, pursuant to the Securities Purchase Agreement dated
as of July 30, 2014 (the “Securities Purchase Agreement”), among the Company and the Investors named therein, the undersigned, Sam Solomon, in his capacity as Chief Executive Officer of the Company, hereby certifies to the
Investors on behalf of the Company that: 
  

	 	1.	The representations and warranties of the Company set forth in Section 4 of the Securities Purchase Agreement are true and correct in all material respects as of the date when made and as of the Closing as
though made on and as of such date. 

  

	 	2.	The Company has performed and complied with, in all material respects, all covenants and agreements, and satisfied all conditions, required by the Transaction Documents to be performed, complied with or satisfied by it
at or prior to the Closing. 

  

	 	3.	Trading in the Common Stock has not been suspended by the SEC or any Trading Market (except for any suspensions of trading of not more than one Trading Day solely to permit dissemination of material information
regarding the Company) at any time since the date of execution of the Securities Purchase Agreement, and the Common Stock has been at all times since such date listed for trading on a Trading Market. 

Capitalized terms used herein and not defined herein shall have the meanings assigned to such terms in the Securities Purchase Agreement. 

[Signature page follows.] 

 IN WITNESS WHEREOF, the undersigned has affixed his signature hereto this 30th day of July, 2014.

  

			
	EveryWare Global, Inc.
		
	 By:
	 	  

		 	 Name: Sam Solomon

		 	 Title: Chief Executive Officer

 [Signature page to Officer’s Certificate] 

 Exhibit D 

EVERYWARE GLOBAL, INC. 

SECRETARY’S CERTIFICATE 

The undersigned, Erika Schoenberger, Secretary of EveryWare Global, Inc., a Delaware corporation (the “Company”), hereby
certifies that she has been duly elected, qualified and is acting in such capacity and that, as such, she is familiar with the facts herein certified and is duly authorized to certify the same, and hereby further certifies, in connection with the
issuance and sale of an aggregate of 21,200 shares (the “Preferred Shares”) of the Company’s Series A Preferred Stock, par value $0.0001 per share (the “Preferred Stock”) and warrants (the
“Warrants”) to purchase 4,438,004 shares (the “Warrant Shares” and, together with this Preferred Shares and the Warrants, the “Securities”)) of the Company’s common stock, par value $0.0001 per
share pursuant to the Securities Purchase Agreement dated July 30, 2014 (the “Securities Purchase Agreement”), among the Company and the Investors named therein, to the Investors, that: 

 

	 	1.	Attached hereto as Annex A is a true and correct copy of the Certificate of Incorporation of the Company as in full force and effect on the date hereof and as certified by the Secretary of State of the State of
Delaware (the “Charter”). No amendment or other modification affecting the Charter has been filed, recorded or executed other than as shown in such Annex A, and no authorization for the filing, recording or execution of any
such amendment or modification is outstanding, and no legally binding action has been taken or, to the knowledge of the undersigned, is pending or is contemplated for the merger of the Company into another company, or for the consolidation or sale
of all or a material part of the assets or business of the Company, or for the dissolution, liquidation or winding up of the Company or threatening the existence of the Company. 

 

	 	2.	Attached hereto as Annex B is a true and correct copy of the By-Laws of the Company as in full force and effect on the date hereof (the “Bylaws”). To the knowledge of the undersigned, no proposal
for any amendment to the Bylaws of the Company is currently pending before the Board of Directors of the Company (the “Board of Directors”). 

  

	 	3.	Attached hereto as Annex C are true and correct copies of resolutions adopted at a meeting of the Board of Directors on July 30, 2014 approving the transactions contemplated by the Securities Purchase
Agreement, and the other Transaction Documents and the issuance of the Securities. The foregoing resolutions adopted in the actions taken by unanimous written consent were duly adopted in accordance with Delaware law and the Charter and Bylaws. The
foregoing resolutions adopted in the actions taken by written consent have not been repealed or amended and are in full force and effect. No other resolutions or consents have been adopted by the Board of Directors or any committee of the Board of
Directors relating to the transactions contemplated by the Securities Purchase Agreement. Each person executing each consent as a member of the Board of Directors was, and at all times since the date of such consent has been, a duly elected and
incumbent member of the Board of Directors. 

	 	4.	The persons whose names appear on Annex D are duly qualified and acting officers of the Company, duly elected or appointed to the offices set forth opposite their respective names, and the signature set opposite
the names of the officers are their authentic signatures. 

 Capitalized terms used but not defined herein shall have the
respective meanings ascribed to such terms in the Securities Purchase Agreement. 
 [Remainder of This Page Left Intentionally Blank]

 IN WITNESS WHEREOF, the undersigned has executed this Certificate as of this 30th day of
July, 2014. 
  

			
	  

	Erika Schoenberger
	Secretary

 I, Sam Solomon, the Chief Executive Officer of the Company, hereby certify that Erika Schoenberger is
the duly elected, qualified and acting Secretary of the Company and that the signature appearing above is his genuine signature. 
 IN
WITNESS WHEREOF, the undersigned has executed this Certificate as of this 30th day of July, 2014. 
  

	
	  

	Sam Solomon
	Chief Executive Officer

 [Signature page to Secretary’s Certificate] 

 CHARTER 

 BYLAWS 

 RESOLUTIONS OF THE BOARD OF DIRECTORS 

					
	 Name
	  	 Office
	  	 Signature

	 Sam Solomon
	  	Chief Executive Officer	  	  

			
	 Erika Schoenberger
	  	Secretary	  	  

			
	 Bernard Peters
	  	Chief Financial Officer	  	  

 Exhibit E  

Everyware Global, Inc. 

Investor Officer’s Certificate 

In connection with the issuance and sale by EveryWare Global, Inc., a Delaware corporation, (the “Company”) of an aggregate
of 21,200 shares of the Company’s Series A Preferred Stock, par value $0.0001 per share and warrants to purchase 4,438,004 shares of the Company’s common stock, par value $0.0001 per share pursuant to the Securities Purchase Agreement
dated as of July 30, 2014 (the “Securities Purchase Agreement”), among the Company and the Investors named therein, the undersigned, Andrea Cipriani, in her capacity as the Chief Financial Officer and Chief Compliance Officer
of [INVESTOR] (the “Investor”), hereby certifies to the Company on behalf of the Investor that: 
  

	 	1.	The representations and warranties of the Investor set forth in Section 5 of the Securities Purchase Agreement are true and correct in all material respects as of the date when made and as of the Closing as
though made on and as of such date. 

  

	 	2.	The Investor has performed and complied with, in all material respects, all agreements and conditions contained in the Securities Purchase Agreement required to be performed or complied with prior to or at the Closing.

 Capitalized terms used herein and not defined herein shall have the respective meanings assigned to such terms in the
Securities Purchase Agreement. 
 [Signature page follows.] 

 IN WITNESS WHEREOF, the undersigned has affixed his signature hereto this 30th day of July, 2014.

  

			
	 [INVESTOR]

		
	By	 	  

		 	 Name:

		 	 Title:

 [Signature page to Investor Officer’s Certificate] 

 Schedule 4.5 

Capitalization 
  

					
	 Shares of Common Stock underlying outstanding options
	  	 	234,563.00	  
	 Shares of Common Stock underlying outstanding warrants
	  	 	5,838,334.00	  

 Schedule 4.11 

Consents 
  

	1.	The filing of the COD with the Secretary of State of the State of Delaware 

  

	2.	Approval of the Warrant Shares for listing on NASDAQ and upon official notice of issuance 

  

	3.	The stockholder approval contemplated by Section 7.3 

  

	4.	Consents, authorization, orders, filings and registrations in connection with the exercise of any registration rights set forth in the Registration Rights Agreement 

 Schedule 5.3 

Broker-Dealer Affiliations 
 None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]